Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3005082	s-prog	nmol/l (nmol/l)	2489	3381	0.00%
3005082	s-prog	— (—)	283	322	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Medical treatment for female infertility

955

1208

8.56

307.65

1.6

1.3

33.46

31.21

nmol/l

1.15

906

1090

Female infertility

1554

336

30.88

307.65

1.4

1.3

34.68

23.38

nmol/l

13.35

1475

300

Female infertility, associated with anovulation

463

214

24.38

307.65

1.6

1.3

32.06

26.14

nmol/l

2.03

429

192

Female infertility, cervical, vaginal, other or unspecified origin

1479

328

32.42

307.65

1.4

1.3

34.82

23.77

nmol/l

12.44

1405

292

Noninflammatory disorders of female genital tract

650

355

9.40

307.65

1.4

1.2

33.63

22.90

nmol/l

9.67

602

317

Procreative management

383

402

8.09

260.43

1.5

1.3

34.11

24.60

nmol/l

5.36

365

347

Polycystic ovarian syndrome, broad definition

509

1009

5.48

245.60

1.5

1.4

30.72

32.35

nmol/l

0.51

470

940

Endometriosis diagnosis and infertility diagnosis occurring together

279

404

7.28

184.13

1.6

1.4

34.46

29.42

nmol/l

1.45

264

358

Female infertility, tubal origin

104

24.21

145.09

1.3

1.2

35.41

20.42

nmol/l

3.07

Pregnancy examination and test

340

389

5.62

144.98

1.4

1.3

35.94

25.23

nmol/l

6.23

321

340

Endometriosis

322

321

5.96

142.98

1.5

1.3

33.25

23.48

nmol/l

4.95

303

285

Endometriosis of ovary

173

188

9.15

139.74

1.5

1.3

32.91

22.83

nmol/l

3.16

168

165

Endometriosis of pelvic peritoneum

169

200

8.20

123.95

1.5

1.3

31.43

22.16

nmol/l

3.06

154

175

Genitourinary diseases

282

230

6.18

119.67

1.4

1.2

33.93

22.71

nmol/l

5.79

250

204

Unspecified/other endometriosis

136

168

8.32

102.62

1.6

1.3

31.97

22.90

nmol/l

2.41

125

150

Excessive, frequent and irregular menstruation

296

351

4.67

100.27

1.4

1.2

31.97

23.03

nmol/l

4.66

268

313

Pain and other conditions associated with female genital organs and menstrual cycle

191

342

5.21

89.73

1.4

1.3

35.71

22.98

nmol/l

6.15

170

305

Ovarian cyst

248

339

4.26

77.61

1.4

1.3

30.09

22.84

nmol/l

2.76

218

301

Outcome of delivery

251

382

4.15

77.60

1.3

34.00

25.41

nmol/l

4.27

235

334

Supervision of high-risk pregnancy

251

391

3.93

71.92

1.5

1.3

32.18

25.16

nmol/l

2.65

227

341

Polycystic ovarian syndrome

203

546

3.96

66.48

1.4

29.34

31.49

nmol/l

0.44

189

497

Amenorrhoea

141

7.21

66.14

1.4

1.3

28.58

22.67

nmol/l

0.74

125

Ovarian dysfunction

224

674

3.48

61.63

1.4

29.28

32.29

nmol/l

0.69

208

612

Medicines for HER+ breast cancer

168

385

4.17

61.33

2.0

1.3

33.06

30.98

nmol/l

0.33

163

330

Dysplasia of cervi uteri

181

316

4.19

60.74

1.3

29.90

24.00

nmol/l

1.97

172

282

Polyp of the female genital tract

148

163

5.25

58.30

1.5

1.3

38.17

21.45

nmol/l

6.82

138

143

Persons encountering health services in circumstances related to reproduction

219

420

3.53

57.17

1.4

1.3

32.45

24.49

nmol/l

2.94

195

362

Antenatal screening

239

398

3.42

55.41

1.4

1.3

31.75

25.26

nmol/l

2.41

220

348

Other abnormal products of conception

495

1532

2.17

51.06

1.4

1.3

35.85

31.01

nmol/l

2.72

462

1409

Disorders of other endocrine glands

301

1277

2.34

40.86

1.4

28.56

32.25

nmol/l

1.21

277

1175

Spontaneous abortion

465

1574

2.01

39.91

1.5

1.3

34.58

31.02

nmol/l

1.79

441

1450

Gestational diabetes (for exclusion)

543

2034

1.88

38.45

1.4

29.71

32.21

nmol/l

1.19

496

1879

Other complications of labour and delivery, not elsewhere classified

296

1227

2.28

36.33

1.4

1.3

36.96

32.65

nmol/l

1.55

276

1141

Oligomenorrhoea

9.21

36.09

1.5

1.2

26.11

21.32

nmol/l

0.44

Other obstetric conditions, not elsewhere classified

540

1920

1.81

33.47

1.4

32.33

31.67

nmol/l

0.20

505

1762

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

537

1917

1.80

32.69

1.4

32.55

31.70

nmol/l

0.27

502

1760

Endometriosis ASRM stages 3,4

212

900

2.38

30.24

1.6

1.4

32.45

31.17

nmol/l

0.24

203

814

Pregnancy, childbirth and the puerperium

198

401

2.60

28.87

1.5

1.3

31.86

29.10

nmol/l

0.57

179

364

Postpartum care and examination

165

384

2.76

28.39

1.4

1.3

27.13

25.45

nmol/l

0.27

148

337

Other maternal disorders predominantly related to pregnancy

471

1677

1.77

27.48

1.4

1.3

28.61

33.00

nmol/l

2.72

428

1554

Diabetes mellitus in pregnancy

448

1652

1.75

25.23

1.5

1.3

28.71

33.06

nmol/l

2.36

404

1533

Supervision of normal pregnancy

174

398

2.52

24.61

1.3

33.55

25.26

nmol/l

2.88

160

348

Delivery, wide proxy

240

591

2.17

24.05

1.4

1.3

31.13

30.87

nmol/l

0.05

220

545

Endocrine, nutritional and metabolic diseases

525

1619

1.65

22.71

1.4

1.3

29.76

33.37

nmol/l

1.92

470

1508

Caries of enamel

466

2038

1.65

22.12

1.4

30.96

31.82

nmol/l

0.26

430

1863

Polycystic ovarian syndrome, consortium definition

560

2122

1.57

20.66

1.4

30.57

32.04

nmol/l

0.52

504

1963

Ectopic pregnancy

138

591

2.36

19.51

1.5

1.3

29.31

30.00

nmol/l

0.10

128

542

Disorders of the thyroid gland

514

2140

1.57

19.34

1.4

28.88

32.33

nmol/l

1.82

467

1980

Special screening examination for infectious and parasitic diseases

278

1130

1.83

18.70

1.3

1.4

32.29

33.20

nmol/l

0.22

259

1059

Complications of labour and delivery

419

1434

1.63

17.97

1.5

1.3

30.31

31.30

nmol/l

0.28

384

1310

Single delivery by caesarean section

235

714

1.91

17.16

1.4

33.00

31.63

nmol/l

0.28

216

667

Endometriosis ASRM stages 1,2

171

843

2.05

17.11

1.5

1.4

31.40

31.36

nmol/l

0.01

156

762

Statin medication

1159

0.39

16.64

1.3

1.4

20.50

30.26

nmol/l

2.88

1039

Diabetes, insulin treatment (Kela reimbursement)

1261

0.40

16.38

1.3

1.4

19.25

30.75

nmol/l

4.86

1128

Finngen Rheumatological endpoints

221

2242

0.56

16.06

1.4

32.93

31.37

nmol/l

0.28

192

2063

Other noninflammatory disorders of vulva and perineum

105

4.13

16.05

1.5

1.3

28.85

21.21

nmol/l

1.17

Hypothyroidism, other/unspecified

487

2119

1.52

15.87

1.4

28.63

32.45

nmol/l

2.09

437

1961

Any event in cancer register

165

1875

0.52

15.75

1.3

1.4

27.88

31.43

nmol/l

1.06

151

1704

Hypothyroidism and >3 levothyroxin purchases

300

994

1.72

15.67

1.4

1.3

29.02

34.47

nmol/l

2.60

272

949

Hypothyroidism, levothyroxine purchases

300

994

1.72

15.67

1.4

1.3

29.02

34.47

nmol/l

2.60

272

949

Hypothyroidism (congenital or acquired)

300

994

1.72

15.61

1.4

1.3

28.86

34.47

nmol/l

2.75

272

949

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1207

0.41

14.89

1.3

19.25

30.51

nmol/l

4.71

1078

Hypothyreosis and Thyroxine purchase for inclusion criteria

490

2162

1.49

14.79

1.4

28.54

32.45

nmol/l

2.19

440

1998

Perineal laceration during delivery

268

1335

1.70

14.42

1.4

1.3

32.49

32.22

nmol/l

0.05

252

1237

Fall on same level

273

2435

0.61

14.10

1.4

31.39

31.58

nmol/l

0.03

247

2239

Behavioural syndromes associated with physiological disturbances and physical factors

450

2145

1.49

13.85

1.3

1.4

32.69

31.51

nmol/l

0.35

404

1978

Irregular menses

401

2099

1.52

13.54

1.4

30.76

32.11

nmol/l

0.37

358

1942

Persons encountering health services for specific procedures and health care

230

2313

0.59

13.40

1.4

30.52

31.40

nmol/l

0.18

204

2126

Hypothyroidism, strict autoimmune

436

1925

1.49

13.38

1.4

28.79

33.03

nmol/l

2.32

390

1784

Other bacterial diseases

141

1713

0.52

13.30

1.3

1.4

27.13

31.45

nmol/l

0.95

122

1557

Pregnancy with abortive outcome

468

1651

1.48

13.27

1.4

1.3

33.98

30.73

nmol/l

1.50

428

1522

Long labour

256

1320

1.67

13.22

1.4

1.3

33.46

31.55

nmol/l

0.50

239

1206

Deep endometriosis

394

2.37

13.22

1.7

1.3

31.47

32.24

nmol/l

0.09

348

Maternal care related to the fetus and amniotic cavity and possible delivery problems

353

1328

1.57

13.15

1.4

1.3

31.85

31.54

nmol/l

0.07

326

1227

Labour and delivery complicated by fetal stress [distress]

328

1366

1.59

13.03

1.4

1.3

32.13

31.75

nmol/l

0.09

307

1252

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

195

2197

0.58

12.95

1.3

1.4

29.01

31.38

nmol/l

0.51

167

2020

Autoimmune diseases excluding thyroid diseases, strict definition

213

1978

0.59

12.87

1.3

1.4

26.55

32.98

nmol/l

3.70

190

1833

Delivery

240

738

1.72

12.66

1.4

31.44

31.32

nmol/l

0.02

217

687

Postpartum haemorrhage

264

1368

1.64

12.53

1.4

1.3

31.34

31.68

nmol/l

0.07

237

1252

Diseases of oesophagus, stomach and duodenum

192

1978

0.58

12.46

1.3

1.4

29.30

31.46

nmol/l

0.46

169

1807

Autoimmune diseases excluding thyroid diseases

221

2009

0.60

12.45

1.3

1.4

27.29

32.81

nmol/l

2.50

198

1861

Maternal care for other known or suspected fetal problems

321

1300

1.58

12.40

1.4

1.3

29.62

31.70

nmol/l

0.69

296

1203

Sleep disorders

434

2145

1.47

12.36

1.3

1.4

32.70

31.51

nmol/l

0.35

387

1978

Haemorrhage in early pregnancy

239

1409

1.66

12.35

1.4

1.3

29.15

33.09

nmol/l

1.45

216

1303

Other intervertebral disc disorders

128

1480

0.52

12.20

1.3

1.4

27.89

31.60

nmol/l

0.71

109

1360

Anxiety (asthma-related co-morbidities)

382

1981

1.50

12.20

1.4

29.69

32.69

nmol/l

1.12

345

1839

Oral corticosteroids

228

2220

0.61

12.19

1.4

31.56

31.37

nmol/l

0.03

199

2043

Insomnia

440

2221

1.45

11.77

1.3

1.4

31.25

31.51

nmol/l

0.07

398

2050

All anxiety disorders

397

2141

1.47

11.66

1.4

29.87

32.31

nmol/l

0.86

359

1978

Nerve, nerve root and plexus disorders

196

2014

0.59

11.54

1.4

24.35

31.73

nmol/l

3.83

167

1847

Chronic apical periodontitis

273

2407

0.64

11.27

1.3

1.4

30.22

31.77

nmol/l

0.41

236

2223

Influenza and pneumonia

236

2389

0.63

11.20

1.3

1.4

29.48

31.82

nmol/l

0.70

206

2200

Pain in limb

192

2139

0.60

11.09

1.3

1.4

29.40

32.34

nmol/l

0.82

170

1988

Other heart diseases, wide

186

1906

0.60

10.94

1.3

1.4

26.99

31.50

nmol/l

1.58

162

1735

Malignant neoplasm, wide definition for exclusion

103

1191

0.51

10.72

1.4

24.91

30.56

nmol/l

1.49

1057

Other menopausal disorders

3.14

10.72

1.1

1.3

14.74

19.83

nmol/l

0.59

All pneumoniae

203

2207

0.61

10.66

1.3

1.4

29.07

31.60

nmol/l

0.68

178

2024

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

105

1310

0.51

10.60

1.2

1.4

25.19

30.56

nmol/l

1.58

1172

Menorrhagia

245

2.20

10.58

1.2

1.3

27.12

22.45

nmol/l

0.92

214

Maternal care for known or suspected fetal abnormality and damage

222

1182

1.63

10.49

1.6

1.3

35.11

32.20

nmol/l

0.71

200

1101

Cardiovascular diseases (excluding rheumatic etc)

257

2275

0.65

10.42

1.3

1.4

29.09

32.15

nmol/l

1.12

219

2112

Pain in throat and chest

178

1788

0.60

10.40

1.4

31.53

31.39

nmol/l

0.02

161

1648

Abnormalities of breathing

238

2161

0.64

10.35

1.3

1.4

29.87

31.75

nmol/l

0.51

205

2001

Pneumonias (Asthma/COPD co-morbidities)

202

2189

0.62

10.29

1.3

1.4

29.09

31.53

nmol/l

0.64

177

2007

Polyarthropathies

106

1328

0.52

10.23

1.4

30.33

31.54

nmol/l

0.14

1205

Solid cancers, helper endpoint

996

0.47

10.21

1.4

24.45

30.15

nmol/l

1.33

879

Metabolic disorders

1159

0.51

9.95

1.2

1.4

25.98

30.49

nmol/l

0.93

1037

Inflammatory bowel disease treatment related agents

289

2396

0.67

9.68

1.4

32.33

31.48

nmol/l

0.18

253

2211

Malignant neoplasm

1026

0.49

9.66

1.4

24.43

30.01

nmol/l

1.33

906

Artrosis, including avohilmo

1034

0.52

9.51

1.4

26.97

29.96

nmol/l

0.61

921

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

188

2057

0.62

9.39

1.3

1.4

28.88

31.44

nmol/l

0.68

164

1886

ILD medications: prednisolone, methylprednisolone, prednisone

281

2322

0.68

9.28

1.5

1.4

30.58

31.86

nmol/l

0.29

247

2143

Symptoms and signs involving cognition, perception, emotional state and behaviour

174

1930

0.61

9.24

1.4

26.34

31.56

nmol/l

2.08

156

1760

Hypertensive diseases

907

0.49

9.10

1.3

1.4

28.06

29.83

nmol/l

0.19

800

Hypertension

906

0.49

9.08

1.3

1.4

28.06

29.87

nmol/l

0.20

799

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

203

1924

0.64

9.01

1.3

1.4

29.50

32.09

nmol/l

0.68

179

1782

203

1924

0.64

9.01

1.3

1.4

29.50

32.09

nmol/l

0.68

179

1782

Hypothyroidism, strict autoimmune, 3 medication purchases required

436

2144

1.38

8.83

1.4

28.59

32.43

nmol/l

2.00

389

1980

Hypertension, essential

797

0.47

8.76

1.2

1.3

26.13

29.74

nmol/l

0.43

700

Tonsillectomy and adenotomy

421

2135

1.38

8.58

1.3

1.4

34.53

31.29

nmol/l

1.35

389

1957

Obstructed labour due to malposition and malpresentation of fetus

209

1254

1.56

8.55

1.3

31.54

31.55

nmol/l

0.00

196

1143

Other bacterial diseases

107

1295

0.55

8.45

1.3

1.4

27.37

31.01

nmol/l

0.58

1167

Dentofacial anomalies [including malocclusion]

391

2274

1.38

8.45

1.4

31.77

31.65

nmol/l

0.03

359

2089

Disorders of gallbladder, biliary tract and pancreas

147

1537

0.60

8.44

1.3

1.4

25.00

30.65

nmol/l

1.46

125

1393

Hypertensive diseases (excluding secondary)

899

0.50

8.41

1.3

1.4

28.58

30.60

nmol/l

0.22

804

Single delivery by forceps and vacuum extractor

188

705

1.62

8.26

1.4

32.41

31.66

nmol/l

0.12

178

658

Tramadol

128

1337

0.59

8.13

1.4

25.29

30.97

nmol/l

1.28

104

1215

Sleep apnoea, including avohilmo

125

1313

0.59

7.88

1.3

1.4

18.52

31.18

nmol/l

7.34

1182

All kidney diseases

234

2346

0.68

7.71

1.4

31.07

31.21

nmol/l

0.02

202

2164

Periodontitis

132

1465

0.60

7.70

1.5

1.4

25.52

30.90

nmol/l

1.55

113

1327

ILD medications

312

2368

0.71

7.68

1.4

30.93

31.78

nmol/l

0.19

274

2187

Substance abuse, excluding more controls

1312

0.53

7.65

1.3

1.4

23.46

32.71

nmol/l

3.20

1222

Sleep apnoea

1024

0.54

7.56

1.3

1.4

18.43

30.30

nmol/l

4.41

910

Chronic periodontitis, including avohilmo

132

1458

0.61

7.50

1.5

1.4

25.52

30.89

nmol/l

1.54

113

1320

Neurotic, stress-related and somatoform disorders

413

2150

1.35

7.42

1.4

29.47

32.23

nmol/l

1.06

370

1983

Anxiety disorders

414

2149

1.34

7.38

1.4

29.45

32.24

nmol/l

1.08

371

1982

Maternal care for known or suspected malpresentation of fetus

243

1203

1.48

7.31

1.4

1.3

31.55

32.10

nmol/l

0.11

219

1112

Dyspnoea

150

1756

0.63

7.27

1.3

1.4

28.88

31.52

nmol/l

0.60

129

1603

Other soft tissue disorders, not elsewhere classified

265

2203

0.70

7.16

1.4

28.80

32.27

nmol/l

1.30

235

2048

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

889

0.52

7.12

1.2

1.4

27.92

30.83

nmol/l

0.50

797

Diarrhoea and gastroenteritis of presumed infectious origin

423

2103

1.33

6.91

1.3

1.4

30.41

31.83

nmol/l

0.43

387

1931

Triptan medication for migraine, single purchase ok

404

2057

1.33

6.80

1.4

29.94

32.00

nmol/l

0.84

367

1894

Migraine, single triptan purchase ok & required. ICD-code if available is included

404

2057

1.33

6.80

1.4

29.94

32.00

nmol/l

0.84

367

1894

ILD medications: immunosuppressive drugs

110

1705

0.60

6.79

1.3

1.4

31.98

31.43

nmol/l

0.06

1561

Pneumonia, organism unspecified

166

1770

0.66

6.67

1.3

1.4

28.67

31.35

nmol/l

0.68

147

1625

Arthrosis

648

0.50

6.61

1.5

1.3

28.70

30.49

nmol/l

0.19

568

Erysipelas

695

0.44

6.59

1.3

1.4

30.46

30.64

nmol/l

0.01

618

Use of hypnotics and sedatives

213

1770

0.69

6.50

1.3

1.4

30.69

30.80

nmol/l

0.02

183

1618

Cystitis

434

1970

1.31

6.44

1.4

32.98

31.23

nmol/l

0.57

398

1804

Injuries to the knee and lower leg

318

2389

0.74

6.43

1.3

1.4

28.00

32.06

nmol/l

2.20

291

2193

Cholelithiasis, broad definition with cholecystitis

130

1386

0.63

6.32

1.3

1.4

25.72

30.71

nmol/l

1.04

110

1250

Injuries to the shoulder and upper arm

102

1373

0.60

6.30

1.3

1.4

31.08

31.40

nmol/l

0.04

1246

Shoulder lesions

820

0.55

6.27

1.3

1.4

21.01

30.76

nmol/l

2.89

737

Other diseases of intestines

310

2384

0.74

6.26

1.4

31.75

31.58

nmol/l

0.03

273

2201

Spondylopathies

768

0.54

6.22

1.2

1.3

36.45

30.77

nmol/l

0.45

690

Lower back pain or/and sciatica

269

2419

0.72

6.22

1.4

28.77

31.87

nmol/l

1.02

229

2236

Exposure to unspecified factor

246

2463

0.72

6.13

1.4

31.75

31.54

nmol/l

0.04

224

2262

Low back pain

210

2123

0.71

5.67

1.4

28.08

32.12

nmol/l

1.33

182

1971

Other degenerative diseases of the nervous system

346

0.28

5.66

1.3

1.4

32.02

32.45

nmol/l

0.02

309

Second line medication for Crohn's disease

1459

0.59

5.60

1.3

1.4

30.15

30.85

nmol/l

0.08

1321

L04AX Other immunosuppressants

1345

0.58

5.59

1.3

1.4

30.03

30.68

nmol/l

0.07

1219

Intracranial trauma

167

1717

0.68

5.58

1.3

1.4

25.92

32.79

nmol/l

2.90

143

1598

Lumbar disc prolapse

1199

0.61

5.56

1.3

1.4

25.77

31.64

nmol/l

1.71

1089

Other nutritional deficiencies

327

2336

1.32

5.52

1.5

1.3

24.24

32.64

nmol/l

8.14

287

2160

Anxiety disorders, excluding more controls

360

1788

1.31

5.51

1.4

29.31

32.88

nmol/l

1.37

324

1662

Unspecified mental disorder

1337

0.58

5.48

1.3

1.4

20.56

31.62

nmol/l

5.76

1230

Cholelithiasis

127

1347

0.65

5.48

1.3

1.4

25.64

30.72

nmol/l

1.03

107

1212

Cardiac arrhythmias

149

1443

0.67

5.47

1.3

25.92

31.79

nmol/l

2.00

127

1318

Persons encountering health services for other counselling and medical advice, not elsewhere classified

421

1780

1.29

5.42

1.3

32.40

31.54

nmol/l

0.22

387

1632

Mental and behavioural disorders due to psychoactive substance use

1335

0.60

5.32

1.3

1.4

24.49

31.80

nmol/l

2.24

1222

Other specific joint derangements/joint disorders

252

2205

0.74

5.30

1.4

28.20

32.31

nmol/l

1.55

224

2036

Other disorders of ear

112

1150

0.64

5.28

1.3

1.4

29.60

30.84

nmol/l

0.16

100

1032

Injuries to the head

297

2411

0.76

5.22

1.3

1.4

27.17

32.09

nmol/l

2.67

264

2221

Chronic diseases of tonsils and adenoids

373

1822

1.30

5.22

1.4

34.68

31.69

nmol/l

0.97

339

1675

Kela-code for severe mental illness

1062

0.54

5.20

1.4

18.12

31.82

nmol/l

6.13

968

Factors influencing health status and contact with health services

114

2.16

5.19

1.2

1.3

35.92

31.67

nmol/l

0.33

106

Type 2 diabetes, wide definition

514

0.47

5.17

1.3

21.66

29.77

nmol/l

1.29

447

Disorders of adult personality and behaviour

1467

0.62

5.04

1.2

1.4

23.83

32.42

nmol/l

2.39

1359

Ischemic heart diseases

334

0.38

5.03

1.4

1.3

18.84

28.65

nmol/l

0.74

276

Substance abuse

1274

0.60

5.02

1.3

1.4

23.46

31.93

nmol/l

2.76

1166

Codeine or tramadol medication

330

2331

0.77

4.86

1.3

1.4

29.57

32.00

nmol/l

0.90

285

2161

Cardiovascular diseases

325

2251

0.77

4.73

1.4

28.60

32.41

nmol/l

1.87

291

2099

Alcohol use disorder, Swedish definition

896

0.55

4.67

1.3

1.4

24.63

31.31

nmol/l

1.31

809

Single spontaneous delivery

196

738

1.41

4.64

1.3

1.4

32.95

31.32

nmol/l

0.34

180

687

Hard cardiovascular diseases

420

0.47

4.64

1.4

1.3

18.21

28.76

nmol/l

1.63

353

Failed induction of labour

537

1.64

4.56

1.4

1.3

32.44

32.75

nmol/l

0.04

494

Schizophrenia or delusion, excluding more controls

887

0.55

4.44

1.5

1.4

17.60

32.68

nmol/l

6.07

819

1145

0.62

4.42

1.2

1.4

24.50

31.38

nmol/l

1.76

1043

Other and unspecified tonsillitis

154

1825

0.71

4.38

1.4

31.55

32.19

nmol/l

0.12

147

1705

Disorders of choroid and retina

720

0.57

4.37

1.5

1.4

31.62

30.67

nmol/l

0.06

648

Schizophrenia or delusion

891

0.55

4.37

1.5

1.4

17.60

31.54

nmol/l

5.41

813

Schizophrenia, schizotypal and delusional disorders

891

0.55

4.36

1.5

1.4

17.60

31.54

nmol/l

5.41

813

Diabetic maculopathy

274

0.31

4.35

1.0

1.7

18.27

29.19

nmol/l

—

247

Other disorders of urethra and urinary system

171

1711

0.72

4.33

1.3

1.4

30.03

30.85

nmol/l

0.15

161

1566

Hernia

140

1347

0.70

4.32

1.3

1.4

28.89

30.63

nmol/l

0.33

124

1214

Other and unspecified nonorganic psychotic disorders

703

0.50

4.31

1.5

1.4

17.04

31.28

nmol/l

3.80

636

Other heart diseases

986

0.65

4.20

1.3

1.4

28.97

31.27

nmol/l

0.39

894

Emotionally unstable personality disorder

845

0.55

4.09

1.1

1.4

25.78

32.05

nmol/l

1.04

770

First line medication for Crohn's disease

343

2327

0.80

4.07

1.4

30.64

31.67

nmol/l

0.27

305

2150

Codeine

322

2211

0.79

4.06

1.4

29.77

32.12

nmol/l

0.84

279

2055

Any death

156

0.23

4.04

1.0

1.3

29.80

28.80

nmol/l

—

128

Maternal care for known or suspected abnormality of pelvic organs

241

1246

1.32

4.04

1.4

1.3

33.10

31.98

nmol/l

0.21

212

1152

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

210

1925

0.75

4.03

1.3

1.4

29.89

31.47

nmol/l

0.35

182

1758

Constipation

116

1175

0.68

4.03

1.3

1.4

31.23

30.57

nmol/l

0.08

104

1055

Renal tubulo-interstitial diseases

200

1988

0.75

4.00

1.4

32.15

31.34

nmol/l

0.13

172

1836

Personality disorders, excluding more controls

1366

0.66

3.91

1.2

1.4

24.47

32.96

nmol/l

2.30

1278

Congenital malformations of genital organs

540

1.58

3.88

1.5

1.4

31.62

31.45

nmol/l

0.02

486

Complications of surgical and medical care, not elsewhere classified

233

2078

0.77

3.87

1.4

27.28

31.74

nmol/l

2.00

202

1908

Recurrent or chronic depression

197

1032

1.34

3.78

1.3

1.4

28.74

32.97

nmol/l

1.28

175

970

Exposure to other specified factors

188

2293

0.75

3.74

1.5

1.4

30.62

31.38

nmol/l

0.12

167

2111

Personality disorders

1350

0.66

3.70

1.2

1.4

24.47

32.24

nmol/l

1.99

1250

Benzodiazepine use

271

2365

0.79

3.65

1.4

30.15

31.79

nmol/l

0.39

236

2180

Mental and behavioural disorders due to alcohol, excluding acute intoxication

738

0.55

3.65

1.3

1.4

24.06

31.15

nmol/l

1.14

665

Depression

395

2186

1.23

3.64

1.4

27.54

32.58

nmol/l

2.99

346

2025

Heart failure, not strict

353

0.46

3.64

1.0

1.3

19.77

30.03

nmol/l

1.03

300

Other retinal disorders

576

0.55

3.57

1.4

27.57

31.05

nmol/l

0.31

515

Contraceptive management

406

1.54

3.56

1.3

27.17

24.73

nmol/l

0.34

351

Salpingitis and oophoritis

292

1.75

3.56

1.5

1.3

21.52

31.77

nmol/l

2.06

253

Condition for Implicit Sepsis (Organ dysfunction codes)

182

1667

0.75

3.55

1.3

1.4

26.36

31.87

nmol/l

2.06

161

1530

Disorders of lipoprotein metabolism and other lipidaemias

434

0.54

3.52

1.1

1.3

25.04

29.75

nmol/l

0.48

374

Artificial joint operation, meniscal resection

611

0.61

3.51

1.4

1.3

27.24

29.09

nmol/l

0.19

532

Autoimmune diseases related-to ILD

212

2349

0.77

3.50

1.4

32.06

31.44

nmol/l

0.11

193

2152

1084

0.66

3.45

1.2

1.4

25.21

30.91

nmol/l

1.30

991

Specific personality disorders

1195

0.66

3.43

1.2

1.4

24.21

32.04

nmol/l

1.84

1101

Postmenopausal atrophic vaginitis

3.05

3.42

1.7

1.1

24.26

11.16

nmol/l

—

Poisoning by drugs, medicaments and biological substances

976

0.62

3.42

1.2

1.4

25.23

31.64

nmol/l

1.32

892

Alcohol use disorder, ICD-based

712

0.56

3.40

1.3

1.4

24.06

31.15

nmol/l

1.14

640

Mycoses

335

2367

1.23

3.39

1.4

29.77

31.84

nmol/l

0.74

310

2172

Herpesviral keratitis and keratoconjunctivitis

2.93

3.30

1.7

1.1

30.21

34.02

nmol/l

0.19

Open wound of wrist and hand

1263

0.68

3.28

1.3

1.4

34.75

31.88

nmol/l

0.47

1160

Sub-endpoint used in defining T1D endpoints

742

0.58

3.27

1.3

1.4

19.18

31.65

nmol/l

3.15

672

Suicide or other Intentional self-harm

854

0.61

3.27

1.3

1.4

23.77

32.10

nmol/l

2.18

772

Placental disorders

2.74

3.27

1.2

1.4

27.37

32.83

nmol/l

0.43

MS-disease / Multiple Sclerosis

310

0.35

3.25

1.4

1.3

35.70

32.98

nmol/l

0.10

275

False labour

266

1315

1.27

3.24

1.4

1.3

30.91

31.58

nmol/l

0.13

243

1215

Demyelinating diseases of the central nervous system

338

0.38

3.22

1.3

32.02

32.64

nmol/l

0.03

296

Reimbursement for rheumatic diseases

1234

0.68

3.22

1.3

1.4

34.88

30.62

nmol/l

0.49

1118

Condition for Implicit Sepsis (Organ dysfunction codes)

143

1366

0.74

3.22

1.3

1.4

25.80

31.66

nmol/l

1.75

126

1252

Disorders of tooth development and eruption

114

650

1.42

3.21

1.2

1.4

31.73

32.75

nmol/l

0.15

107

607

Conductive and sensorineural hearing loss

592

0.61

3.16

1.2

1.4

28.31

29.79

nmol/l

0.11

518

Major coronary heart disease event

256

0.45

3.15

1.4

1.3

16.82

28.01

nmol/l

0.82

206

Poisoning by medicine

900

0.63

3.06

1.3

1.4

26.31

31.91

nmol/l

1.00

819

Biguanides

268

1306

1.25

3.03

1.5

1.3

27.71

31.21

nmol/l

1.25

244

1182

Other arrhythmias

112

1173

0.72

3.01

1.3

1.4

26.42

31.12

nmol/l

1.12

1060

Insulin, fast-acting or short human

773

0.61

3.01

1.3

1.4

18.68

31.47

nmol/l

3.68

702

Dizziness and giddiness

131

1403

0.74

2.98

1.4

25.76

31.00

nmol/l

1.94

120

1272

Complications of the puerperium, not elsewhere classified

302

1.68

2.98

1.5

1.3

37.26

33.15

nmol/l

0.55

270

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

718

0.60

2.94

1.3

1.4

25.89

31.42

nmol/l

0.96

648

Concussion

150

1614

0.76

2.90

1.4

25.36

32.66

nmol/l

2.83

128

1503

Gonarthrosis [arthrosis of knee](FG)

338

0.55

2.87

1.4

1.2

32.36

28.37

nmol/l

0.32

275

L04AA Selective immunosuppressants

457

0.50

2.87

1.4

1.3

34.39

31.11

nmol/l

0.11

400

STROKE

358

0.53

2.86

1.2

1.3

18.51

30.43

nmol/l

2.41

308

Insulin, fast-acting

762

0.62

2.86

1.3

1.4

18.68

31.58

nmol/l

3.73

696

Campylobacter enteritis

3.18

2.85

1.3

1.4

33.90

38.72

nmol/l

0.26

Any reimbursement code in KELA

318

1933

0.82

2.83

1.3

1.4

30.41

32.70

nmol/l

0.69

278

1800

Prolonged pregnancy

182

1237

1.29

2.82

1.3

34.81

32.14

nmol/l

0.61

172

1151

Other and unspecified mood [affective] disorders

426

0.49

2.81

1.4

25.63

32.45

nmol/l

0.98

391

Coronary revascularization (ANGIO or CABG)

238

0.46

2.77

1.4

1.3

18.22

27.61

nmol/l

0.60

191

Persons encountering health services in other circumstances, wide

411

1780

1.19

2.77

1.4

1.3

31.64

31.54

nmol/l

0.02

375

1632

Percutaneous Coronary Intervention

238

0.46

2.77

1.4

1.3

18.22

27.61

nmol/l

0.60

191

Conjunctivitis

339

2359

1.20

2.74

1.4

32.20

31.54

nmol/l

0.16

314

2162

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

133

1567

0.75

2.72

1.3

1.4

25.53

32.64

nmol/l

2.37

113

1465

Other diseases of urinary system

415

1971

1.18

2.71

1.4

32.23

31.21

nmol/l

0.29

383

1805

Emergency coronary revascularization (for ACS)

234

0.47

2.71

1.4

1.3

18.22

27.45

nmol/l

0.58

189

Examination and observation for other reasons

246

1146

1.24

2.65

1.4

29.49

32.99

nmol/l

1.19

224

1071

Intestinal infectious diseases

423

2050

1.18

2.65

1.3

1.4

28.76

31.92

nmol/l

1.39

382

1883

Insulin medication

921

0.69

2.62

1.4

1.3

19.38

31.37

nmol/l

4.42

840

Other antidepressants

288

1790

0.82

2.61

1.3

1.4

27.54

32.47

nmol/l

2.40

255

1676

Insulin, intermediate and long-acting

806

0.65

2.60

1.4

18.38

31.48

nmol/l

4.17

732

Bleeding

813

0.70

2.59

1.2

1.4

27.82

31.20

nmol/l

0.49

733

Gastro-oesophageal reflux disease

1094

0.72

2.59

1.4

28.11

30.54

nmol/l

0.35

986

Sensorineural hearing loss

457

0.61

2.58

1.3

1.4

26.74

30.09

nmol/l

0.23

398

Type 1 diabetes

701

0.63

2.54

1.3

19.18

31.61

nmol/l

3.14

639

Mental and behavioural disorders due to alcohol

1010

0.69

2.54

1.2

1.4

23.81

30.86

nmol/l

1.73

919

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

334

2218

1.19

2.53

1.3

1.4

30.73

32.15

nmol/l

0.42

316

2030

Postpartum hemorraghe, parous women as controls

264

1847

1.22

2.53

1.4

31.34

32.40

nmol/l

0.25

237

1710

Asthma/COPD (KELA code 203)

277

2295

0.83

2.52

1.3

1.4

31.50

31.69

nmol/l

0.03

249

2116

Infections of the skin and subcutaneous tissue

130

1689

0.76

2.51

1.3

1.4

30.79

31.82

nmol/l

0.15

118

1551

Complications predominantly related to the puerperium

209

1682

1.25

2.49

1.4

33.76

31.88

nmol/l

0.41

193

1560

Rotator cuff syndrome

451

0.60

2.49

1.3

22.62

31.11

nmol/l

1.22

390

Hydatidiform mole

2.59

2.46

1.5

1.3

35.88

26.49

nmol/l

0.63

Falls/tendency to fall

381

2244

0.85

2.45

1.3

1.4

31.69

31.75

nmol/l

0.01

347

2062

Multiple gestation

538

1.44

2.44

1.4

27.80

31.42

nmol/l

0.50

497

Diseases of arteries, arterioles and capillaries

377

0.57

2.43

1.2

1.3

27.43

30.87

nmol/l

0.28

327

Gonarthrosis

314

0.58

2.42

1.4

1.3

32.36

30.90

nmol/l

0.10

261

Pure hypercholesterolaemia

324

0.56

2.39

1.1

1.3

25.72

30.31

nmol/l

0.40

280

Iron deficiency anaemia secondary to blood loss (chronic)

146

1.85

2.36

1.2

1.3

36.19

32.98

nmol/l

0.16

125

Acute upper respiratory infections of multiple and unspecified sites

330

2063

1.19

2.35

1.3

1.4

28.96

31.89

nmol/l

1.14

292

1900

Arthropathies

371

2206

0.85

2.35

1.4

29.03

32.29

nmol/l

1.42

342

2037

Injuries to the elbow and forearm

168

1859

0.79

2.34

1.4

30.05

31.67

nmol/l

0.35

154

1710

Other anxiety disorders

293

2125

1.20

2.34

1.4

30.32

32.39

nmol/l

0.58

263

1971

Other (not insulin) diabetes medications

283

1394

1.21

2.32

1.6

1.3

29.34

31.19

nmol/l

0.51

257

1264

Type 2 diabetes, strict (exclude DM1)

276

1342

1.21

2.32

1.7

1.3

30.07

30.94

nmol/l

0.18

250

1216

Disorders of conjunctiva

346

2361

1.18

2.29

1.4

31.95

31.51

nmol/l

0.10

321

2164

Focal epilepsy

421

0.54

2.28

1.2

1.4

27.07

31.99

nmol/l

0.40

373

Any event in hilmo or specialist outpatient

5.51

2.27

1.0

30.63

24.72

nmol/l

—

Type 2 diabetes, definitions combined

276

1346

1.20

2.26

1.7

1.3

30.07

30.98

nmol/l

0.19

250

1220

Other joint disorders

357

2205

0.85

2.23

1.4

28.26

32.31

nmol/l

2.01

330

2036

Dorsalgia

344

2159

0.85

2.18

1.4

29.01

32.10

nmol/l

1.18

301

2006

Viral haemorrhagic fevers, not elsewhere classified/unspecified

296

1.56

2.17

1.4

26.96

32.71

nmol/l

0.86

266

Fever of other and unknown origin

124

1426

0.77

2.17

1.4

32.50

32.21

nmol/l

0.04

110

1321

Implicit Sepsis

137

1280

0.78

2.17

1.3

1.4

26.16

31.52

nmol/l

1.45

120

1174

Type 1 diabetes, wide definition

661

0.65

2.16

1.3

19.18

31.98

nmol/l

3.27

600

Insulin, combination of fast acting with intermediate-acting or long-acting

962

0.72

2.16

1.4

19.38

31.35

nmol/l

4.40

881

Opioids

369

2232

0.86

2.16

1.4

28.91

32.10

nmol/l

1.38

331

2074

Varicose veins

371

0.59

2.15

1.3

28.52

28.43

nmol/l

0.01

305

Neoplasms

453

2086

1.15

2.15

1.3

1.4

32.01

31.83

nmol/l

0.05

416

1931

Obesity and other hyperalimentation

286

2325

1.19

2.14

1.5

1.3

23.20

32.55

nmol/l

8.96

248

2150

Unspecified maternal hypertension

2.25

2.13

1.5

1.4

28.71

31.71

nmol/l

0.19

Fall on same level involving ice and snow

1267

0.75

2.13

1.3

1.4

31.32

31.13

nmol/l

0.02

1152

Antihypertensive medication - note that there are other indications

360

2216

0.86

2.06

1.3

1.4

25.79

32.73

nmol/l

5.78

319

2071

Type 1 diabetes, wide definition, subgroup 1

651

0.66

2.03

1.3

19.18

31.92

nmol/l

3.24

590

Maternal care for known or suspected disproportion

175

0.40

2.03

1.0

1.3

46.24

29.63

nmol/l

—

151

Obesity

284

2324

1.18

2.02

1.5

1.3

23.25

32.56

nmol/l

8.86

247

2149

Asthma, including avohilmo

457

2244

1.14

2.02

1.4

31.17

31.70

nmol/l

0.14

414

2065

Disorders of eyelid in diseases classified elsewhere

2.37

1.95

1.4

1.3

31.82

34.40

nmol/l

0.10

Inflammatory diseases of female pelvic organs

363

2310

1.16

1.95

1.5

1.4

29.53

32.04

nmol/l

0.97

323

2136

Schizoaffective disorder

228

0.44

1.93

1.4

1.3

21.09

34.02

nmol/l

—

201

Hyperkinetic disorders, excluding more controls

929

0.73

1.93

1.2

1.4

20.97

33.34

nmol/l

3.66

866

Carrier of infectious disease

2.07

1.91

1.3

1.4

44.27

35.61

nmol/l

0.32

Gonarthrosis,primary

263

0.59

1.91

1.4

1.2

31.86

24.37

nmol/l

0.57

203

Mucosal proctocolitis

372

0.56

1.91

1.6

1.3

36.37

32.63

nmol/l

0.17

329

Sciatica+with lumbago

1156

0.76

1.91

1.3

1.4

26.54

31.57

nmol/l

1.00

1051

Postpartum hemorraghe, all women as controls

264

2206

1.18

1.91

1.4

31.34

32.32

nmol/l

0.23

237

2040

Atopic dermatitis

318

2240

1.16

1.91

1.4

33.63

31.19

nmol/l

0.78

294

2061

Acute sinusitis

175

1975

0.82

1.90

1.3

1.4

30.49

32.01

nmol/l

0.29

159

1822

Arthropod-borne viral fevers and viral haemorrhagic fevers

323

1.49

1.89

1.4

27.22

32.58

nmol/l

0.84

290

Disorders of synovium and tendon

129

1423

0.79

1.88

1.3

1.4

29.40

31.61

nmol/l

0.41

111

1306

Fracture of lower leg, including ankle

1071

0.75

1.88

1.4

23.73

31.48

nmol/l

2.15

969

Epilepsy

683

0.69

1.85

1.3

1.4

28.76

31.52

nmol/l

0.27

624

Focal epilepsy, mode (most common among epilepsy diagnosis)

354

0.56

1.83

1.3

1.4

24.48

32.68

nmol/l

0.66

312

Other external causes of accidental injury

300

1751

0.86

1.82

1.4

31.10

31.33

nmol/l

0.05

269

1607

Migraine

314

2196

1.16

1.82

1.4

29.91

32.18

nmol/l

0.70

283

2037

All chronic kidney diseases

684

0.72

1.82

1.5

1.4

34.50

30.82

nmol/l

0.26

615

Mental disorders, not otherwise specified

378

0.58

1.81

1.2

1.4

27.19

32.86

nmol/l

0.73

340

Ovarian dysfunction, other/unspecified

3.11

1.81

1.3

1.2

10.07

35.17

nmol/l

—

Focal epilepsy, strict definition

353

0.57

1.81

1.3

1.4

23.31

32.65

nmol/l

0.90

311

Allergic conjunctivitis

269

2241

1.17

1.79

1.5

1.4

32.84

31.28

nmol/l

0.39

248

2050

Malignant neoplasm of breast, ER-negative, including Hilmo

159

0.42

1.78

1.1

1.3

22.02

27.56

nmol/l

—

132

Burn and corrosion of hip and lower limb, except ankle and foot

2.36

1.78

1.4

1.3

17.54

36.59

nmol/l

1.55

Type 2 diabetes, definitions combined, including avohilmo

280

1391

1.17

1.78

1.7

1.3

29.84

31.12

nmol/l

0.29

252

1263

Inguinal hernia

496

0.70

1.78

1.3

1.4

31.89

30.68

nmol/l

0.14

440

Medical abortion

258

1644

0.85

1.77

1.3

30.80

30.77

nmol/l

0.01

228

1515

Disorders of psychological development

563

0.67

1.77

1.3

1.4

29.64

32.37

nmol/l

0.21

519

Diseases of middle ear and mastoid

325

2305

1.15

1.76

1.3

1.4

32.38

31.93

nmol/l

0.10

296

2138

Cerebrovascular diseases

361

0.64

1.76

1.3

21.81

30.34

nmol/l

1.59

311

Candidiasis

134

1074

1.25

1.76

1.3

1.4

31.24

31.77

nmol/l

0.08

126

989

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

259

2150

1.17

1.75

1.5

1.4

32.35

31.42

nmol/l

0.20

238

1963

Diaphragmatic hernia

232

1.55

1.75

1.5

1.3

21.14

29.69

nmol/l

1.12

198

Mood [affective] disorders

385

2186

1.14

1.74

1.4

28.28

32.58

nmol/l

2.20

336

2025

Acute pharyngitis

774

0.72

1.74

1.2

1.4

30.55

31.85

nmol/l

0.16

709

Other disorders of veins

589

0.67

1.73

1.2

1.3

23.51

31.05

nmol/l

1.23

512

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

132

1630

0.80

1.73

1.4

25.83

33.17

nmol/l

3.31

116

1527

Mood disorders

385

2186

1.14

1.71

1.4

28.28

32.58

nmol/l

2.20

336

2025

Soft tissue disorders

376

2205

0.88

1.69

1.4

29.09

32.26

nmol/l

1.39

337

2049

Dislocation, sprain and strain of joints and ligaments of knee

180

1990

0.83

1.69

1.3

1.4

29.15

31.89

nmol/l

0.74

162

1824

Carpal tunnel syndrome

986

0.77

1.67

1.3

1.4

24.17

31.15

nmol/l

1.54

880

Primary amenorrhea

2.29

1.65

1.4

1.2

40.61

37.36

nmol/l

0.06

Implicit Sepsis

107

1021

0.79

1.65

1.3

1.4

21.39

31.51

nmol/l

3.88

932

Disturbance of activity and attention

891

0.74

1.65

1.1

1.4

21.69

31.72

nmol/l

2.54

822

Premature rupture of membranes

209

1260

1.19

1.64

1.4

1.3

32.74

32.01

nmol/l

0.14

194

1169

Injuries to the thorax

655

0.70

1.64

1.5

1.4

25.71

30.65

nmol/l

0.73

593

Caries of dentine, including avohilmo

195

1188

0.84

1.61

1.4

33.07

32.68

nmol/l

0.06

170

1113

Type 1 diabetes, definitions combined

413

0.63

1.61

1.3

1.4

18.78

31.95

nmol/l

2.06

367

Type 1 diabetes, strict (exclude DM2)

413

0.63

1.61

1.3

1.4

18.78

31.95

nmol/l

2.06

367

Diabetic maculopathy, excluding more controls

189

0.48

1.60

1.0

1.3

18.27

33.81

nmol/l

—

166

Subacute thyroiditis

2.07

1.60

1.4

1.3

31.82

37.68

nmol/l

0.32

Maternal care for other conditions predominantly related to pregnancy

183

1504

1.20

1.59

1.4

1.3

31.91

33.63

nmol/l

0.38

164

1402

Diverticular disease of intestine

242

0.61

1.58

1.4

1.2

9.21

25.84

nmol/l

4.40

196

Disorders of breast

164

1784

0.83

1.55

1.3

1.4

31.21

31.30

nmol/l

0.01

144

1632

Exclusions for E4_PCOS_CONSORTIUM

297

2132

0.87

1.54

1.3

1.4

32.36

31.24

nmol/l

0.26

269

1957

Gastrointestinal diseases

296

1704

0.87

1.54

1.3

1.4

28.78

32.50

nmol/l

1.53

270

1580

Accidents

305

1751

0.87

1.53

1.4

31.78

31.33

nmol/l

0.11

273

1607

COPD/asthma related infections

338

1926

0.88

1.53

1.4

28.74

32.05

nmol/l

1.48

301

1784

COPD/asthma/ILD related infections

338

1926

0.88

1.53

1.4

28.74

32.05

nmol/l

1.48

301

1784

Unspecified fall

1019

0.77

1.52

1.4

29.46

31.22

nmol/l

0.25

934

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

1.52

0.0

1.2

—

15.96

—

Poor fetal growth

144

1187

1.22

1.52

1.3

1.4

30.06

32.27

nmol/l

0.45

133

1093

Injuries to the wrist and hand

304

2405

0.87

1.52

1.4

32.58

31.43

nmol/l

0.29

276

2210

Hyperkinetic disorders

911

0.76

1.52

1.2

1.4

20.97

31.61

nmol/l

2.88

841

Disorders of eyelid, lacrimal system and orbit

175

1582

0.84

1.52

1.3

1.4

31.28

30.86

nmol/l

0.06

154

1436

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

132

1608

0.82

1.50

1.4

25.83

32.34

nmol/l

2.71

116

1490

Symptoms and signs involving the digestive system and abdomen

360

1589

1.14

1.50

1.4

30.78

31.94

nmol/l

0.32

320

1474

Other ulcerative colitis

127

0.39

1.49

1.4

1.3

45.12

31.66

nmol/l

—

108

Acute suppurative otitis media

137

1550

0.82

1.49

1.4

28.16

32.18

nmol/l

1.10

128

1444

Melanocytic naevi

117

945

1.24

1.49

1.4

35.18

31.32

nmol/l

0.77

866

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

157

1856

0.83

1.49

1.2

1.4

27.88

32.21

nmol/l

1.54

146

1718

Burn and corrosion of trunk

2.44

1.48

1.4

1.2

26.93

34.69

nmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

215

2256

0.86

1.47

1.4

29.11

31.88

nmol/l

0.82

194

2075

Symptoms and signs involving the urinary system

103

981

0.80

1.47

1.3

1.4

28.75

30.80

nmol/l

0.37

886

Post-traumatic stress disorder

639

0.72

1.46

1.5

1.4

26.80

32.10

nmol/l

0.76

586

Other salmonella infections

2.38

1.45

1.2

1.3

29.64

28.63

nmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

332

2215

1.13

1.44

1.3

1.4

30.78

32.14

nmol/l

0.39

315

2027

Congenital malformations, deformations and chromosomal abnormalities

297

2404

1.14

1.42

1.3

1.4

32.74

31.49

nmol/l

0.34

275

2205

Bronchitis

406

2285

1.12

1.40

1.4

29.77

31.86

nmol/l

0.76

358

2112

Diseases of the digestive system

700

0.74

1.40

1.3

1.4

20.30

30.64

nmol/l

2.87

633

Rheumatoid arthritis, including avohilmo

576

0.71

1.39

1.3

1.4

28.75

30.68

nmol/l

0.12

513

Female genital prolapse

100

1.58

1.39

1.1

1.2

19.91

22.30

nmol/l

0.18

Scar conditions and fibrosis of skin

1.84

1.35

1.6

1.4

26.50

33.51

nmol/l

0.49

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

155

1829

0.84

1.35

1.4

31.21

31.83

nmol/l

0.12

141

1693

Chronic hepatitis, not elsewhere classified

0.00

1.34

0.0

1.2

—

33.64

—

Melanocytic naevi of trunk

324

1.39

1.33

1.3

1.4

28.72

32.41

nmol/l

0.42

292

Abdominal and pelvic pain

356

1589

1.13

1.33

1.4

30.97

31.94

nmol/l

0.26

317

1474

Pre-eclampsia or poor fetal growth

241

2095

1.15

1.33

1.3

1.4

29.37

32.35

nmol/l

1.00

219

1931

Injuries to the hip and thigh

558

0.73

1.31

1.3

1.4

40.39

30.43

nmol/l

1.21

496

Myalgia

820

0.77

1.31

1.4

23.17

31.61

nmol/l

1.96

753

External causes of morbidity and mortality

274

1564

0.88

1.31

1.4

32.26

31.77

nmol/l

0.10

240

1443

Acute tubulo-interstitial nephritis

159

1618

0.85

1.30

1.3

1.4

30.12

31.61

nmol/l

0.30

141

1496

Symptoms and signs involving the nervous and musculoskeletal systems

108

1318

0.82

1.30

1.1

1.4

25.67

31.21

nmol/l

1.25

1202

Exclusions for E4_PCOS_BROAD

437

1.33

1.29

1.3

1.4

35.14

31.12

nmol/l

0.32

384

Hodgkin lymphoma, hilmo

2.09

1.28

1.6

1.2

32.36

30.83

nmol/l

—

Other disorders of eyelid

223

1.45

1.27

1.3

27.88

29.39

nmol/l

0.12

190

Disorders of thyroid, IBD co-morbidities

707

0.79

1.24

1.3

27.53

33.71

nmol/l

1.45

662

Other and unspecified haemorrhagic conditions

2.41

1.24

1.3

1.2

33.71

31.79

nmol/l

—

Viral and other specified intestinal infections

1140

0.81

1.24

1.4

30.22

33.11

nmol/l

0.41

1055

Childhood allergy (age < 16)

130

1277

0.84

1.23

1.5

1.4

33.70

32.84

nmol/l

0.14

125

1206

Other symptoms and signs involving the nervous and musculoskeletal systems

1078

0.81

1.22

1.1

1.4

23.51

31.35

nmol/l

1.84

976

Triptan medication for migraine, min. 3 purchases

343

2345

1.12

1.22

1.4

29.85

31.92

nmol/l

0.69

315

2157

Acetic acid derivatives and related substances

123

527

1.21

1.4

30.80

34.99

nmol/l

1.00

108

503

Iron deficiency anaemia

100

804

1.23

1.21

1.2

1.4

31.17

31.79

nmol/l

0.08

725

Impetigo

143

0.49

1.20

1.1

1.4

28.36

31.03

nmol/l

—

123

Other contact dermatitis

226

0.57

1.20

1.6

1.3

33.38

32.67

nmol/l

0.05

201

Bacterial pneumoniae

574

0.75

1.20

1.3

1.4

28.31

31.39

nmol/l

0.33

516

Voice disturbances

461

1.30

1.19

1.3

1.4

26.80

30.51

nmol/l

0.56

405

Bacterial pneumonia, not elsewhere classified

533

0.74

1.19

1.3

1.4

28.03

31.29

nmol/l

0.34

478

Used for control exclusion in common control thyroid runs

427

1952

1.11

1.19

1.4

28.80

32.79

nmol/l

2.11

389

1807

Convulsions, not elsewhere classified

697

0.76

1.19

1.2

1.4

29.45

31.65

nmol/l

0.23

649

Donors of organs and tissues

2.12

1.19

1.6

1.2

31.27

31.96

nmol/l

—

Anorexia (incl.atypical)

419

1.32

1.18

1.4

35.93

33.26

nmol/l

0.21

388

Cholecystectomy

114

1181

0.83

1.17

1.3

1.4

22.55

30.41

nmol/l

2.65

1059

Benign neoplasm: Rectum

2.00

1.16

1.4

1.1

14.65

27.07

nmol/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

125

0.57

1.16

1.8

1.3

26.50

30.24

nmol/l

—

113

Valvular operations

0.00

1.16

0.0

1.1

—

31.65

—

Other arthrosis

272

0.69

1.13

1.6

1.2

20.35

30.16

nmol/l

1.34

225

Transport accidents

172

1709

0.86

1.12

1.4

32.63

31.59

nmol/l

0.18

161

1575

Biological medication for rheuma

562

0.75

1.11

1.2

1.4

33.96

31.03

nmol/l

0.29

499

Postviral fatigue syndrome

2.21

1.08

1.4

1.1

29.21

35.70

nmol/l

—

Obesity related asthma

575

1.25

1.08

1.5

1.4

24.05

31.70

nmol/l

1.29

513

Headache

285

2036

1.12

1.08

1.4

28.41

32.12

nmol/l

1.44

254

1886

Other disorders of amniotic fluid and membranes

137

1141

1.18

1.07

1.4

31.04

32.18

nmol/l

0.21

128

1063

Contusion of other and unspecified parts of foot

180

0.55

1.06

1.4

28.95

30.64

nmol/l

—

161

Chromosomal abnormalities, not elsewhere classified

1.76

1.06

1.4

45.84

36.42

nmol/l

0.58

Autoimmune diseases

437

2028

1.10

1.06

1.4

28.40

32.68

nmol/l

2.68

397

1878

Diseases of appendix

215

2193

0.88

1.06

1.5

1.4

29.45

31.75

nmol/l

0.62

200

2002

Certain infectious and parasitic diseases

349

1932

0.90

1.05

1.3

1.4

29.51

31.73

nmol/l

0.79

313

1776

Secondary uncertain malignant neoplasm

1.79

1.04

1.5

1.3

28.31

32.39

nmol/l

0.25

Sulfasalazine

668

0.78

1.03

1.2

1.3

37.52

31.58

nmol/l

0.54

604

Other reaction to severe stress, and adjustment disorders

158

1821

0.87

1.03

1.4

27.60

32.45

nmol/l

1.28

137

1686

Haemangioma, any site

130

1.54

1.02

1.3

1.4

32.64

31.80

nmol/l

0.04

110

Diseases of pulp and periapical tissues, including avohilmo

365

2080

0.91

1.02

1.4

30.77

31.94

nmol/l

0.34

325

1938

Diseases of pulp and periapical tissues and dental caries

153

909

0.86

1.01

1.4

32.18

32.96

nmol/l

0.12

134

850

Bacterial infection, other or unspecified

667

0.80

1.01

1.2

1.4

25.01

30.88

nmol/l

1.17

598

Other dorsopathies, not elsewhere classified

376

2160

0.91

1.01

1.4

29.43

32.09

nmol/l

1.13

341

2007

Asthma, unspecified (mode), excluding more controls

138

1201

0.86

1.00

1.4

29.10

31.91

nmol/l

0.53

119

1114

Nutritional anaemias

105

849

1.19

1.00

1.2

1.4

30.45

31.35

nmol/l

0.12

766

GASTRO-related operations

407

1863

1.10

1.00

1.3

1.4

29.85

32.40

nmol/l

1.07

370

1725

Any gastric operation

407

1863

1.10

1.00

1.3

1.4

29.85

32.40

nmol/l

1.07

370

1725

Appendicitis, broad definition

215

2191

0.89

1.00

1.5

1.4

29.45

31.76

nmol/l

0.62

200

2000

Episodal and paroxysmal disorders

395

2201

0.91

1.00

1.3

1.4

28.91

32.14

nmol/l

1.59

363

2040

Pre-eclampsia

117

993

1.18

0.99

1.3

1.4

27.82

31.68

nmol/l

0.89

105

913

Complications of medical and surgical care

155

1639

0.87

0.99

1.4

27.63

30.93

nmol/l

0.99

134

1493

Chronic rhinitis, nasopharyngitis and pharyngitis

101

846

1.19

0.99

1.5

1.4

33.69

31.16

nmol/l

0.41

771

Malignant neoplasm of breast, HER-negative

129

0.53

0.98

1.1

1.3

22.02

27.23

nmol/l

—

103

Benign neoplasm: Rectum, anus and anal canal

1.80

0.98

1.4

1.3

13.97

29.69

nmol/l

1.13

Gout, unspecified

0.00

0.97

0.0

1.1

—

25.73

—

Varicose veins of other sites

0.00

0.97

0.0

1.4

—

28.15

—

Nonorganic sleeping disorders

830

1.19

0.97

1.3

1.4

29.02

31.41

nmol/l

0.29

753

Deviated nasal septum

379

1.29

0.97

1.4

22.75

31.31

nmol/l

1.94

338

Benign neoplasm: Brain, supratentorial

0.00

0.96

0.0

1.2

—

36.11

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

570

0.77

0.96

1.4

33.85

31.05

nmol/l

0.24

516

Brain meningioma

0.00

0.96

0.0

1.3

—

24.04

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

570

0.77

0.96

1.4

33.85

31.05

nmol/l

0.24

516

Other sexually transmitted chlamydial diseases

869

0.81

0.96

1.4

29.95

32.47

nmol/l

0.34

801

Dermatitis

135

1556

0.86

0.95

1.4

29.31

30.91

nmol/l

0.28

115

1415

Brain meningioma, including Hilmo

0.00

0.95

0.0

1.3

—

24.08

—

ILD, hospital admission 2, with pulmonary infections

0.00

0.95

0.0

1.2

—

27.01

—

Asthma, unspecified (mode)

138

1202

0.86

0.95

1.4

29.10

31.88

nmol/l

0.52

119

1115

Diseases of the respiratory system

229

1288

0.89

0.95

1.3

1.4

30.41

32.39

nmol/l

0.49

198

1194

Suppurative and unspecified otitis media

190

1902

0.88

0.94

1.4

29.28

31.97

nmol/l

0.74

173

1773

Benign neoplasm: Sigmoid colon

1.77

0.94

2.1

1.2

5.32

25.08

nmol/l

—

Antepartum haemorrhage, not elsewhere classified

634

1.22

0.93

1.3

1.4

34.62

31.60

nmol/l

0.39

587

All dysplastic lesions of the vagina

1.83

0.92

1.2

28.79

29.74

nmol/l

—

Other abnormal auditory perceptions

2.16

0.92

1.0

1.2

45.67

33.39

nmol/l

—

Acute epiglottitis

2.15

0.91

1.5

1.3

32.56

36.71

nmol/l

—

Symptoms and signs involving speech and voice

544

1.23

0.91

1.3

1.4

27.49

30.43

nmol/l

0.42

480

Explicit Sepsis

684

0.80

0.91

1.4

24.62

31.66

nmol/l

1.05

617

Bacterial pneumonia (organism specified)

604

0.80

0.91

1.3

1.4

27.28

30.97

nmol/l

0.45

542

Injuries to the abdomen, lower back, lumbar spine and pelvis

919

0.83

0.90

1.3

1.4

34.05

31.49

nmol/l

0.28

838

Haemangioma and lymphangioma, any site

151

1.46

0.90

1.2

1.3

29.46

31.88

nmol/l

0.12

128

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

280

2206

1.10

0.90

1.4

28.71

32.38

nmol/l

1.57

252

2034

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.08

0.89

1.3

1.2

26.35

34.46

nmol/l

—

Nonorganic sleeping disorders, excluding more controls

838

1.18

0.89

1.3

1.4

29.02

32.91

nmol/l

0.53

777

Necrosis of pulp, including avohilmo

163

1844

0.88

1.4

28.77

31.77

nmol/l

0.67

145

1690

Dorsopathies

391

2161

0.92

0.88

1.4

30.45

32.08

nmol/l

0.50

353

2008

Secondary and unspecified malignant neoplasm of lymph nodes

1.79

0.87

1.6

1.3

32.36

29.43

nmol/l

—

Diseases of the musculoskeletal system and connective tissue

292

1612

0.91

0.86

1.4

27.91

32.78

nmol/l

2.24

259

1510

Dermatitis and eczema

394

2248

1.09

0.86

1.4

34.15

31.11

nmol/l

1.22

360

2067

Pre-eclampsia or eclampsia

119

1027

1.16

0.86

1.3

1.4

27.80

31.78

nmol/l

0.95

106

945

Anisometropia and aniseikonia

1.82

0.86

1.8

1.2

24.36

28.01

nmol/l

—

Coeliac disease

310

0.71

0.85

1.5

1.3

21.61

33.45

nmol/l

2.57

276

Dental pulpitis, including avohilmo

385

2303

1.09

0.83

1.3

1.4

31.62

31.63

nmol/l

0.00

338

2134

Neurological diseases

367

2004

0.92

0.83

1.4

27.62

32.62

nmol/l

3.06

332

1866

Inflammatory bowel disease

886

0.83

0.82

1.4

31.79

31.47

nmol/l

0.03

805

Speech and linguistic disorders, excluding more controls

397

0.76

0.82

1.4

22.69

33.28

nmol/l

1.60

374

359

2016

0.92

0.82

1.4

29.49

32.07

nmol/l

0.86

323

1862

Congenital malformations of ovaries, fallopian tubes and broad ligaments

328

1.29

0.82

1.2

1.3

33.67

32.96

nmol/l

0.06

293

Noninfective enteritis and colitis

104

1207

0.86

0.81

1.4

33.31

31.50

nmol/l

0.21

1101

Anomalies of dental arch relationship, including avohilmo

739

0.83

0.81

1.5

1.4

26.43

31.20

nmol/l

0.82

671

Selective serotonin reuptake inhibitors

314

1791

0.91

0.81

1.4

29.86

32.47

nmol/l

0.85

281

1676

Other symptoms and signs involving the digestive system and abdomen

284

1.30

0.81

1.2

1.4

30.21

29.57

nmol/l

0.04

252

Care involving use of rehabilitation procedures

113

1200

0.87

0.81

1.4

25.02

30.57

nmol/l

1.38

1076

Hypertrophy of breast in women and men

533

0.79

0.81

1.4

31.13

30.10

nmol/l

0.10

473

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.80

0.0

1.2

—

30.60

—

Other and unspecified effects of external causes

1077

0.85

0.80

1.5

1.4

35.68

31.34

nmol/l

0.53

988

Cerebral aneurysm, nonruptured

1.73

0.79

1.3

1.2

25.11

26.80

nmol/l

—

Hypertrophy of breast

531

0.79

1.4

31.13

30.16

nmol/l

0.09

472

Assault by sharp object

0.00

0.79

0.0

1.2

—

33.45

—

Assault by other specified means

0.00

0.79

0.0

1.2

—

33.26

—

Other acute viral hepatitis

0.00

0.79

0.0

1.2

—

31.59

—

Preparatory care for dialysis

0.00

0.79

0.0

1.2

—

28.60

—

Congenital iodine-deficiency syndrome/hypothyroidism

1.82

0.79

1.3

1.2

12.85

29.47

nmol/l

—

Systemic sclerosis

0.00

0.79

0.0

1.1

—

26.93

—

Systemic sclerosis (FG)

0.00

0.79

0.0

1.1

—

28.95

—

Restless leg syndrome

207

1.35

0.79

1.4

1.3

27.31

31.96

nmol/l

0.44

180

Dental caries, including avohilmo

170

979

0.89

0.79

1.4

1.3

32.16

32.59

nmol/l

0.07

150

913

Systemic sclerosis, icd10

0.00

0.78

0.0

1.1

—

26.93

—

Nonsuppurative otitis media

139

1364

0.88

0.78

1.2

1.4

34.92

32.69

nmol/l

0.38

130

1278

Postpartum haemorrhage due to anatomy

120

1371

0.87

0.77

1.5

1.4

28.61

32.54

nmol/l

1.03

105

1282

Tooth eruption problems

1118

0.86

0.76

1.5

1.4

30.89

33.13

nmol/l

0.31

1041

Implicit viral Sepsis

448

1.23

0.76

1.3

1.4

24.18

31.42

nmol/l

1.11

395

Disorders of puberty

1.71

0.76

1.9

1.3

57.90

36.80

nmol/l

—

Non-follicular lymphoma

0.00

0.76

0.0

1.1

—

31.96

—

Abnormal findings on examination of blood, without diagnosis

505

0.80

0.76

1.5

1.4

27.76

31.04

nmol/l

0.42

446

COPD differential diagnosis

279

1529

0.91

0.76

1.4

28.31

32.30

nmol/l

1.74

244

1416

Pregnancy hypertension

267

2189

1.09

0.74

1.4

28.99

32.22

nmol/l

1.25

240

2016

Dipeptidyl peptidase 4 (DPP-4) inhibitors

133

1.38

0.73

2.6

1.2

46.70

24.96

nmol/l

1.96

105

Obesity, other/unspecified

149

1325

1.13

0.73

1.6

1.4

20.39

32.04

nmol/l

8.79

128

1218

Other abortion

1.81

0.73

2.1

1.3

34.34

25.79

nmol/l

—

Peripheral retinal degeneration

2.00

0.72

1.8

1.2

17.04

33.78

nmol/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

254

0.71

0.72

1.2

18.60

29.47

nmol/l

—

213

Glucagon-like peptide-1 (GLP-1) analogues

254

0.71

0.72

1.2

18.60

29.47

nmol/l

—

213

Supplementary factors related to causes of morbidity and mortality classified elsewhere

795

0.84

0.71

1.2

1.4

26.08

31.04

nmol/l

0.91

722

Acute appendicitis

206

2119

0.91

0.70

1.4

28.51

31.69

nmol/l

1.16

191

1930

ILD differential diagnosis

280

1527

0.92

0.70

1.4

28.69

32.26

nmol/l

1.42

245

1414

Cytomegaloviral disease

1.86

0.68

1.4

1.1

28.24

26.82

nmol/l

—

Protozoal diseases

1.86

0.68

1.2

1.1

40.48

30.58

nmol/l

—

Other abnormal immunological findings in serum

1.67

0.68

2.1

1.2

31.51

40.19

nmol/l

—

Bacterial infection, other or unspecified

556

0.83

0.68

1.2

1.4

25.57

31.21

nmol/l

0.92

494

Superficial injuries involving multiple body regions

1.53

0.68

1.1

1.4

36.11

35.56

nmol/l

—

Benign neoplasm of mouth and pharynx

110

1.46

0.68

1.2

1.3

30.83

29.51

nmol/l

0.07

Glomerulonephritis

119

0.59

0.67

1.3

1.4

13.64

31.25

nmol/l

—

Other disorders of breast and lactation associated with childbirth

188

1.34

0.67

1.5

1.3

27.00

36.78

nmol/l

1.51

172

Exclusion endpoint for supernumerary teeth

1.64

0.67

1.3

1.4

30.13

44.20

nmol/l

—

Viral agents as the cause of diseases classified to other chapters

1.63

0.67

1.6

1.2

20.57

27.28

nmol/l

—

Other puerperal infections

771

1.16

0.67

1.5

1.4

36.45

32.26

nmol/l

0.62

704

In situ neoplasms

908

0.86

0.67

1.2

1.4

29.76

31.41

nmol/l

0.24

832

Panic disorder

918

0.86

0.66

1.3

1.4

30.16

32.49

nmol/l

0.23

848

Chronic lower respiratory diseases

404

2301

0.93

0.66

1.4

30.77

31.71

nmol/l

0.25

364

2120

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.79

0.66

1.0

1.1

47.80

32.54

nmol/l

—

Periapical abscess

832

0.85

0.66

1.3

1.4

23.32

31.21

nmol/l

2.27

751

Viral infections of the central nervous system

179

0.67

0.66

1.2

1.4

31.91

32.92

nmol/l

0.05

155

Complications of procedures, not elsewhere classified

207

1877

0.91

0.65

1.4

27.84

31.31

nmol/l

1.25

182

1726

Maternal care for cervical incompetence

180

1.34

0.65

1.6

1.3

34.27

33.43

nmol/l

0.04

164

Peritonsillar abscess

916

0.86

0.65

1.3

1.4

25.55

31.93

nmol/l

1.68

847

Spondyloarthritis

427

0.80

0.64

1.3

1.4

45.81

31.74

nmol/l

0.94

380

Acute upper respiratory infections

360

2067

1.07

0.64

1.3

1.4

29.75

31.86

nmol/l

0.69

327

1902

Leiomyoma of uterus

132

840

0.89

0.64

1.3

30.86

29.80

nmol/l

0.17

123

732

HSIL lesion of the vagina

1.73

0.64

1.0

1.2

34.00

27.94

nmol/l

—

Other protozoal intestinal diseases

1.73

0.64

1.2

1.3

17.90

33.07

nmol/l

—

Chronic tubulo-interstitial nephritis

1.73

0.64

3.2

1.1

122.22

28.95

nmol/l

—

Striking against or struck by other objects

945

0.87

0.63

1.4

29.29

31.32

nmol/l

0.28

861

Other osteochondropathies

131

0.61

0.63

1.0

1.3

26.50

31.12

nmol/l

—

110

Excessive earwax

745

0.85

0.63

1.3

1.4

26.16

30.79

nmol/l

0.97

673

Other superficial mycoses

414

1.21

0.63

1.3

1.4

31.61

32.83

nmol/l

0.12

368

Fracture of foot, except ankle

763

0.85

0.63

1.2

1.4

24.94

31.44

nmol/l

1.59

694

Open wound of head

777

0.86

0.63

1.2

1.4

32.18

31.44

nmol/l

0.09

705

Urticaria and erythema

116

1305

0.89

0.62

1.4

29.91

31.39

nmol/l

0.18

107

1195

Anterior Iridocyclitis

369

0.79

0.61

1.4

1.3

29.26

31.21

nmol/l

0.16

324

Preterm labour and delivery

851

1.14

0.61

1.5

1.3

24.81

31.00

nmol/l

1.82

772

Irritable bowel syndrome

105

927

1.13

0.61

1.3

1.4

30.35

31.39

nmol/l

0.15

847

Other disorders of breast

453

1.19

0.60

1.4

27.80

31.17

nmol/l

0.46

406

Benign neoplasm: Kidney

0.00

0.60

0.0

1.1

—

23.52

—

Simple and mucopurulent chronic bronchitis

0.00

0.60

0.0

1.3

—

35.71

—

Spondylosis

300

0.79

0.60

1.3

1.2

31.50

29.75

nmol/l

0.06

257

Toxic effect of carbon monoxide

0.00

0.59

0.0

1.1

—

34.41

—

Alcohol withdrawal state with delirium

0.00

0.59

0.0

1.2

—

27.11

—

Diabetes mellitus

321

2011

0.93

0.59

1.6

1.3

28.57

31.59

nmol/l

1.05

288

1842

Episcleritis

1.45

0.59

1.6

1.3

40.04

29.79

nmol/l

0.78

Speech and linguistic disorders

383

0.80

0.58

1.4

22.69

32.49

nmol/l

1.43

353

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

0.58

0.0

1.1

—

33.08

—

Vitiligo

0.00

0.58

0.0

1.1

—

31.98

—

Early syphilis

0.00

0.58

0.0

1.1

—

34.77

—

Extreme obesity with alveolar hypoventilation

0.00

0.58

0.0

1.2

—

26.67

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

0.58

0.0

1.2

—

25.81

—

Viral infections characterized by skin and mucous membrane lesions

302

2407

1.07

0.58

1.4

34.05

31.24

nmol/l

0.94

284

2202

Fracture of forearm

117

1197

0.89

0.57

1.4

31.61

31.83

nmol/l

0.03

109

1098

Myeloproliferative diseases (CML excluded)

1.67

0.56

1.5

1.2

29.85

32.66

nmol/l

—

Asthma (mode)

306

1527

1.07

0.56

1.4

30.74

32.26

nmol/l

0.37

277

1414

Other anaemias

356

0.80

0.56

1.2

1.3

21.98

30.86

nmol/l

1.23

311

Diseases of tongue

0.56

1.4

1.3

27.64

34.93

nmol/l

—

Atopic dermatitis, strict definition

156

1676

0.91

0.55

1.5

1.4

30.80

31.92

nmol/l

0.20

142

1556

Injuries to the ankle and foot

256

2444

0.93

0.54

1.3

1.4

30.16

31.75

nmol/l

0.45

237

2245

Lesion of plantar nerve

1.58

0.54

1.2

38.51

23.89

nmol/l

—

Myeloproliferative diseases

1.58

0.54

1.5

1.2

29.84

35.17

nmol/l

—

Benign neoplasms

424

2206

1.06

0.54

1.3

1.4

32.14

31.63

nmol/l

0.14

388

2040

Inflammatory diseases of the central nervous system

126

0.63

0.54

1.1

1.3

24.98

31.29

nmol/l

—

105

Disorders of puberty, all

1.49

0.53

1.8

1.4

60.49

37.75

nmol/l

0.74

Acute and subacute iridocyclitis

350

0.80

0.53

1.3

27.81

31.14

nmol/l

0.29

306

Sequelae of injuries, of poisoning and of other consequences of external causes

437

0.82

0.53

1.2

1.4

27.00

31.04

nmol/l

0.39

388

Hernia of abdominal wall

653

0.86

0.53

1.3

1.4

29.41

30.91

nmol/l

0.14

589

Spondylopathies (FG)

415

0.82

0.53

1.3

1.4

45.81

31.57

nmol/l

0.95

371

Other pulmonary diagnosis

285

1528

0.93

0.52

1.4

28.52

32.31

nmol/l

1.62

249

1416

Excluding asthma or asthma-COPD overlap

285

1528

0.93

0.52

1.4

28.79

32.31

nmol/l

1.39

248

1416

Other and unspecified anaemias

353

0.81

0.52

1.2

1.3

21.98

30.88

nmol/l

1.23

309

Other and unspecified iron deficiency

704

1.14

0.51

1.2

1.4

29.31

31.85

nmol/l

0.43

637

Other acute lower respiratory infections

116

1225

0.90

0.51

1.3

1.4

32.15

31.12

nmol/l

0.14

103

1122

Other disorders of patella

543

0.85

0.51

1.4

33.00

32.56

nmol/l

0.04

491

Scleritis and episcleritis

109

1.38

0.51

1.6

1.3

39.87

30.59

nmol/l

0.74

Obesity due to excess calories

199

1841

1.08

0.50

1.5

1.4

24.26

32.64

nmol/l

5.09

176

1703

Inflammatory disease of cervix uteri

1.47

0.50

1.6

1.3

28.33

28.82

nmol/l

0.02

Paracetamol or NSAID medication

394

0.87

0.50

1.4

38.02

34.45

nmol/l

0.36

379

Chronic sinusitis

125

1131

1.10

0.50

1.4

30.99

31.48

nmol/l

0.06

113

1031

Other neurological diseases

803

0.89

0.50

1.2

1.4

25.75

31.04

nmol/l

1.09

719

Urticaria

103

1145

0.90

0.49

1.4

29.87

31.44

nmol/l

0.17

1048

Pedestrian injured in collision with car, pick-up truck or van

1.56

0.49

1.6

1.2

35.67

40.24

nmol/l

—

Melanocytic naevi of other and unspecified parts of face

145

1.31

0.48

1.1

1.4

43.50

30.59

nmol/l

0.90

125

Covid-19 suspected case

103

926

1.11

0.48

1.3

1.4

26.04

31.71

nmol/l

1.28

849

Contusion of ankle

110

0.63

0.48

1.0

1.4

28.69

30.55

nmol/l

—

Impacted teeth

184

1513

1.08

0.48

1.4

31.13

32.58

nmol/l

0.30

169

1407

Gingival hyperplasia

1.52

0.48

1.9

1.3

17.50

29.98

nmol/l

—

Generalized epilepsy, strict definition

1.45

0.48

1.4

1.5

24.71

38.37

nmol/l

0.65

Anaemias

128

919

0.91

0.48

1.2

1.3

30.52

34.13

nmol/l

0.79

110

875

Placenta praevia

327

1.20

0.47

1.5

1.3

31.89

32.54

nmol/l

0.06

298

Myopia

589

1.14

0.46

1.5

1.4

29.81

31.90

nmol/l

0.28

532

Functional dyspepsia

589

1.14

0.46

1.3

1.4

30.10

30.84

nmol/l

0.08

528

Effects of other external causes

0.61

0.46

1.0

1.4

19.18

33.51

nmol/l

—

Other arthritis (FG)

654

0.87

0.45

1.4

34.46

30.48

nmol/l

0.42

589

Diabetes, varying definitions

318

1975

0.94

0.45

1.6

1.3

28.61

31.61

nmol/l

1.02

285

1809

Intracranial injury

143

1472

0.92

0.45

1.4

26.05

32.27

nmol/l

2.20

123

1367

Acute pancreatitis (for exclusion)

153

0.72

0.45

1.3

10.46

32.96

nmol/l

3.44

125

Conjunctivitis (acute, non atopic)

872

0.89

0.45

1.2

1.4

31.27

31.20

nmol/l

0.01

793

Early onset COPD

103

1.36

0.45

1.1

1.3

28.66

30.73

nmol/l

—

Iridocyclitis

428

0.84

0.45

1.3

1.4

37.79

31.35

nmol/l

0.47

378

Follow-up examination after treatment for conditions other than malignant neoplasms

158

1134

0.92

0.45

1.3

1.4

29.09

32.99

nmol/l

1.10

142

1061

Atopic dermatitis, strict definition with reimbursement

169

1761

0.93

0.44

1.5

1.4

31.43

31.27

nmol/l

0.02

154

1635

Obsessive-compulsive disorder

441

1.16

0.44

1.4

31.20

31.04

nmol/l

0.01

402

Other eating disorders

448

0.85

0.44

1.3

1.4

29.15

32.89

nmol/l

0.34

417

Acute pancreatitis

152

0.72

0.44

1.3

10.46

32.67

nmol/l

3.39

125

Disorders of refraction and accommodation

107

967

1.10

0.44

1.5

1.4

29.78

31.73

nmol/l

0.31

889

Short stature, not elsewhere classified

1.37

0.43

1.2

1.5

24.88

34.09

nmol/l

0.87

Other and unspecified injuries of neck

1.62

0.43

1.0

1.2

36.78

33.66

nmol/l

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

1.62

0.43

2.2

1.2

13.27

38.11

nmol/l

—

Early onset COPD, excluding more controls

104

1.35

0.43

1.1

1.3

28.66

28.42

nmol/l

—

Other congenital malformations of peripheral vascular system

1.57

0.42

1.4

1.2

49.86

43.84

nmol/l

—

Viral agents as the cause of diseases classified to other chapters

1.41

0.42

1.5

1.2

18.13

32.32

nmol/l

—

Internal derangement of knee

866

0.90

0.42

1.4

26.11

31.87

nmol/l

1.08

787

Burns and corrosions of multiple and unspecified body regions

1.52

0.41

1.8

1.2

22.98

35.80

nmol/l

—

Other injuries of spine and trunk, level unspecified

0.00

0.41

0.0

1.1

—

27.91

—

Other congenital malformations of circulatory system

1.52

0.41

1.8

1.1

27.52

33.14

nmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

190

887

1.07

0.41

1.4

1.3

32.79

33.22

nmol/l

0.07

170

828

Macular pucker

0.00

0.41

0.0

1.1

—

21.89

—

Other disorders of lacrimal gland

671

1.12

0.40

1.3

1.4

36.00

30.97

nmol/l

0.60

606

Hyperkalaemia

0.00

0.40

0.0

1.2

—

24.02

—

Excessive attrition of teeth

216

2029

1.07

0.40

1.5

1.4

28.88

31.87

nmol/l

0.82

202

1858

Arterial embolism and thrombosis

0.00

0.40

0.0

1.1

—

31.61

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.31

0.39

1.5

1.3

30.63

38.34

nmol/l

—

Need for other prophylactic measures

1.31

0.39

1.3

1.4

41.63

29.56

nmol/l

—

Pollen allergy

1020

0.91

0.39

1.4

34.70

31.19

nmol/l

0.63

940

Viral meningitis

104

0.67

0.39

1.3

1.4

34.57

33.60

nmol/l

—

Other extrapyramidal and movement disorders in other diseases

306

1.18

0.39

1.4

1.3

28.37

31.14

nmol/l

0.27

269

Asthma

306

1520

1.06

0.39

1.4

30.85

32.34

nmol/l

0.36

276

1409

Type of accident

708

0.89

0.39

1.2

1.4

27.12

30.82

nmol/l

0.58

640

Other and unspecified paralytic syndromes

0.00

0.39

0.0

1.1

—

32.31

—

Aggressive periodontitis

0.00

0.39

0.0

1.2

—

33.93

—

Cough

826

1.10

0.39

1.4

28.44

31.34

nmol/l

0.53

751

Other functional intestinal disorders

832

0.90

0.39

1.3

1.4

30.39

31.19

nmol/l

0.07

756

Viral and other specified intestinal infections

147

1527

0.93

0.39

1.3

1.4

29.65

32.49

nmol/l

0.55

129

1426

All dysplastic lesions of the cervix uteri

187

1979

0.94

0.39

1.3

1.4

29.96

31.68

nmol/l

0.42

176

1817

Other noninfective gastroenteritis and colitis

527

0.87

0.38

1.4

41.43

31.28

nmol/l

0.74

467

Other appendicitis

151

1.26

0.38

2.1

1.3

29.15

31.04

nmol/l

0.06

128

Dermatophytosis

164

1527

1.07

0.38

1.4

27.48

32.05

nmol/l

1.67

150

1397

Other deformities of toe(s)

1.39

0.38

1.0

1.3

23.26

31.41

nmol/l

—

Other diseases of stomach and duodenum

1.39

0.38

1.0

1.1

23.64

31.43

nmol/l

—

Chronic ulcer of skin, not elsewhere classified

1.39

0.38

2.2

1.2

24.27

28.67

nmol/l

—

Migraine with aura

141

1519

0.93

0.38

1.5

1.4

29.72

32.63

nmol/l

0.51

125

1408

Other disorders of fluid, electrolyte and acid-base balance

204

0.79

0.38

1.3

15.26

30.77

nmol/l

2.09

178

Follicular cysts of skin and subcutaneous tissue

289

1.18

0.37

1.3

29.83

32.66

nmol/l

0.23

257

Generalized anxiety disorder

115

1059

1.09

0.37

1.3

1.4

28.63

32.65

nmol/l

0.87

108

980

Zoster [herpes zoster]

740

1.10

0.37

1.4

35.83

30.88

nmol/l

0.74

664

Viral infections of the central nervous system

158

0.76

0.37

1.2

1.4

31.91

32.25

nmol/l

0.02

137

Congenital malformations of the urinary system

134

1.27

0.37

1.3

1.4

26.25

32.33

nmol/l

0.41

118

Nontoxic goitre/thyroid nodule

343

0.85

0.36

1.3

31.66

31.04

nmol/l

0.03

298

Disorders of skin appendages

190

1784

1.06

0.36

1.3

1.4

27.09

32.18

nmol/l

2.31

170

1653

Contact with and exposure to communicable diseases

196

2072

0.94

0.36

1.3

1.4

31.44

31.80

nmol/l

0.07

178

1926

Propionic acid derivatives

534

0.91

0.36

1.4

29.38

35.15

nmol/l

1.21

509

Coagulation defects, purpura and other haemorrhagic conditions

450

1.13

0.36

1.4

28.56

31.90

nmol/l

0.31

399

Superficial injury of neck

0.65

0.36

1.4

37.02

32.79

nmol/l

—

Perioral dermatitis

0.65

0.36

1.2

1.4

33.88

35.51

nmol/l

—

Effects of foreign body entering through natural orifice

441

1.13

0.35

1.3

1.4

40.99

30.56

nmol/l

1.31

390

Asthma-related infections

173

1588

1.07

0.35

1.4

30.19

31.68

nmol/l

0.23

154

1455

Asthma, hospital admission 2, infections

173

1588

1.07

0.35

1.4

30.19

31.68

nmol/l

0.23

154

1455

Asthma, excluding more controls

306

1518

1.05

0.35

1.4

30.85

32.36

nmol/l

0.36

276

1408

Pain in thoracic spine

376

1.14

0.34

1.6

1.4

29.11

31.69

nmol/l

0.25

334

Crohn's disease NAS

163

1.23

0.34

1.4

36.09

32.54

nmol/l

0.16

140

Other symptoms and signs involving cognitive functions and awareness

407

0.87

0.34

1.3

27.34

31.74

nmol/l

0.41

355

Abscess of Bartholin gland

127

1.26

0.33

1.1

1.3

29.65

33.49

nmol/l

0.24

109

Cervicobrachial syndrome

446

0.87

0.33

1.5

1.3

19.07

30.97

nmol/l

2.02

398

Aplastic and other anaemias

396

0.87

0.33

1.1

1.3

25.92

30.91

nmol/l

0.62

348

Visual disturbances

105

1136

0.92

0.33

1.4

33.00

31.46

nmol/l

0.17

1035

Superficial injury of head

498

0.88

0.32

1.3

1.4

19.69

30.69

nmol/l

2.04

444

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

643

0.90

0.32

1.3

1.4

21.80

30.42

nmol/l

1.96

569

Dissociative [conversion] disorders

220

0.82

0.32

1.2

1.4

29.72

32.76

nmol/l

0.13

199

Acute bronchitis

888

0.92

0.32

1.2

1.4

31.58

30.78

nmol/l

0.08

809

Idiopathic thrombocytopenic purpura

1.28

0.32

1.3

1.1

17.45

35.87

nmol/l

—

Other diseases of peritoneum

1.28

0.32

1.3

1.2

12.02

31.41

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

497

0.88

0.32

1.4

33.85

31.85

nmol/l

0.16

444

Abrasion of teeth

684

1.10

0.31

1.3

1.4

26.81

31.28

nmol/l

0.81

614

Injury, poisoning and certain other consequences of external causes

255

1343

0.95

0.31

1.4

32.27

32.30

nmol/l

0.00

221

1244

Intrahepatic Cholestasis of Pregnancy (ICP)

496

0.89

0.31

1.4

33.85

31.92

nmol/l

0.16

443

Specific development disorders of scholastic skills

216

0.82

0.31

1.3

1.5

22.92

32.25

nmol/l

0.71

195

Fibromyalgia

305

0.85

0.31

1.4

1.3

20.16

31.91

nmol/l

1.54

274

Vertical strabismus

1.35

0.31

1.3

24.18

31.32

nmol/l

—

Benign mammary dysplasia

208

0.82

0.31

1.2

1.3

25.94

32.34

nmol/l

0.37

186

Excessive vomiting in pregnancy

456

1.12

0.31

1.3

33.87

34.13

nmol/l

0.02

418

Other disorders of binocular vision

1.32

0.31

1.4

1.5

20.77

38.70

nmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

534

0.92

0.31

1.4

31.57

35.15

nmol/l

0.59

509

Disorders of parathyroid gland

0.73

0.30

1.3

4.44

29.47

nmol/l

—

Crohn's disease of large intestine

131

0.76

0.30

1.5

1.4

29.77

32.58

nmol/l

—

113

Disorders of lacrimal system

808

1.09

0.30

1.3

1.4

35.15

31.04

nmol/l

0.53

725

Stomatitis and related lesions

537

0.89

0.30

1.5

1.4

32.45

31.64

nmol/l

0.04

482

Other and unspecified urticaria

694

0.91

0.30

1.3

1.4

31.13

31.50

nmol/l

0.02

628

Mood disorders, excluding more controls

313

1789

1.04

0.30

1.4

27.98

32.87

nmol/l

2.31

274

1663

Idiopathic urticaria

1.34

0.30

1.5

1.3

36.43

34.25

nmol/l

—

Type 2 diabetes

294

1644

1.04

0.29

1.6

1.3

29.45

31.47

nmol/l

0.54

266

1498

149

1392

1.06

0.29

1.4

31.18

32.14

nmol/l

0.12

133

1283

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

962

0.92

0.29

1.4

27.20

31.47

nmol/l

0.95

879

All dysplastic lesions of the cervix uteri, vagina or vulva

195

2021

0.95

0.29

1.3

1.4

30.27

31.61

nmol/l

0.31

183

1847

Other congenital malformations of the digestive system

110

0.72

0.28

2.3

1.4

35.64

33.00

nmol/l

—

Other diseases of hard tissues of teeth

139

675

1.07

0.28

1.3

1.4

33.82

32.06

nmol/l

0.27

123

626

Other and unspecified dermatitis

124

1320

0.94

0.27

1.4

28.97

30.81

nmol/l

0.32

107

1206

Dental operations

122

669

0.94

0.27

1.3

1.4

33.01

31.83

nmol/l

0.15

103

619

Motorcycle rider injured in other and unspecified transport accidents

119

0.76

0.27

1.9

1.3

34.19

29.76

nmol/l

—

100

Infections with a predominantly sexual mode of transmission

178

1870

0.95

0.27

1.3

1.4

34.02

31.90

nmol/l

0.48

163

1727

Non-allergic asthma

128

0.78

0.27

1.5

1.3

27.48

30.63

nmol/l

—

110

DVT of lower extremities

150

0.80

0.27

1.2

1.3

27.63

32.63

nmol/l

0.30

125

Other and unspecified injuries of ankle and foot

139

0.79

0.27

1.1

1.4

25.87

29.15

nmol/l

0.21

121

Infections with a predominantly sexual mode of transmission

265

2368

1.04

0.27

1.3

1.4

32.79

31.69

nmol/l

0.25

239

2201

Agranulocytosis

128

0.78

0.26

1.0

1.3

19.45

32.58

nmol/l

—

104

Tubulo-interstitial nephritis, not specified as acute or chronic

113

1.24

0.26

1.4

1.3

24.95

31.40

nmol/l

—

Asthma and allergy

769

1.08

0.26

1.3

1.4

33.97

33.54

nmol/l

0.04

722

Anogenital herpesviral [herpes simplex] infection

405

1.11

0.26

1.3

1.4

33.89

32.09

nmol/l

0.17

365

Pain in joint

207

1259

1.05

0.26

1.4

28.30

32.66

nmol/l

1.34

186

1181

Gastric ulcer

0.68

0.26

2.4

1.2

58.90

24.35

nmol/l

—

Inflammatory disorders of breast

446

0.90

0.25

1.4

36.90

31.43

nmol/l

0.43

408

Asthma and allergy, excluding more controls

770

1.08

0.25

1.3

1.4

33.97

33.52

nmol/l

0.04

724

Urolithiasis

341

0.88

0.25

1.3

30.74

32.12

nmol/l

0.08

296

Acute appendicitis, no complications

179

1870

0.95

0.25

1.4

28.94

31.44

nmol/l

0.75

168

1705

Other chronic obstructive pulmonary disease

101

1.22

0.25

1.1

1.3

28.66

28.07

nmol/l

—

Atypical facial pain

1.22

0.25

1.2

1.3

19.80

32.71

nmol/l

—

Impacted cerumen

1.22

0.25

1.3

1.4

27.56

36.68

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

170

0.82

0.25

1.6

1.4

32.36

31.87

nmol/l

0.03

148

Malaise and fatigue

107

917

0.94

0.24

1.2

1.4

32.00

31.44

nmol/l

0.07

854

Injuries involving multiple body regions

1.19

0.24

1.1

1.4

36.11

35.13

nmol/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

112

1054

1.06

0.24

1.5

1.4

32.47

31.92

nmol/l

0.07

102

972

Other specified and unspecified personality disorders

350

0.88

0.24

1.1

1.3

24.73

32.84

nmol/l

1.00

309

Disturbances of skin sensation

1004

0.94

0.24

1.2

1.4

26.82

31.64

nmol/l

1.12

910

Diseases of peritoneum

1.27

0.24

1.2

1.4

14.62

30.62

nmol/l

2.00

Herpesviral [herpes simplex] infections

106

996

1.06

0.24

1.4

36.62

31.64

nmol/l

1.02

101

910

Other peripheral vertigo

0.71

0.24

1.3

1.4

15.02

30.28

nmol/l

—

Parasetamol

350

1714

1.03

0.24

1.4

1.3

30.61

32.63

nmol/l

0.66

312

1597

Calculus of kidney and ureter

328

0.88

0.23

1.3

29.54

31.87

nmol/l

0.13

285

LSIL lesion of the vagina

1.32

0.23

1.0

1.1

25.70

27.67

nmol/l

—

Cystic kidney disease

1.32

0.23

1.2

16.96

37.38

nmol/l

—

Candidiasis

380

0.89

0.23

1.2

1.4

24.03

32.18

nmol/l

1.78

339

Cervical disc disorders

296

0.88

0.23

1.4

1.3

36.62

30.61

nmol/l

0.20

258

Diseases of the eye and adnexa

390

1893

1.03

0.23

1.4

30.31

31.85

nmol/l

0.50

358

1754

Diseases of the skin and subcutaneous tissue

361

1870

0.97

0.23

1.4

28.22

31.75

nmol/l

1.60

317

1730

Complications of genitourinary prosthetic devices, implants and grafts

1.28

0.23

1.2

10.05

31.95

nmol/l

—

Problems related to lifestyle

369

0.89

0.22

1.6

1.4

22.68

30.36

nmol/l

1.07

335

Malignant neoplasm of digestive organs

0.77

0.22

1.3

1.2

19.79

24.69

nmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.76

0.22

1.3

1.4

16.95

34.09

nmol/l

—

Acute peritonitis

1.25

0.22

1.0

1.2

17.74

29.38

nmol/l

—

Symptoms and signs involving the circulatory and respiratory systems

419

2161

0.97

0.22

1.4

30.90

31.75

nmol/l

0.27

380

2001

Other/unspecified synovitis and tenosynovitis

221

0.86

0.22

1.5

1.3

26.71

33.03

nmol/l

0.55

202

Asthma-related pneumonia

543

1.08

0.22

1.3

1.4

28.35

31.36

nmol/l

0.31

486

Bullous disorders

1.22

0.22

1.0

1.2

25.50

34.09

nmol/l

—

Congenital mitral valve regurgitation

0.00

0.21

0.0

1.0

—

30.13

—

Asthma-related pneumonia or sepsis

544

1.08

0.21

1.3

1.4

28.35

31.43

nmol/l

0.32

487

Asthma, hospital admissions 3, pneumonia

544

1.08

0.21

1.3

1.4

28.35

31.43

nmol/l

0.32

487

Disorders of ocular muscles, binocular movement, accommodation and refraction

182

1729

1.04

0.21

1.4

29.41

32.07

nmol/l

0.69

160

1602

Juvenile cataract

0.00

0.21

0.0

1.0

—

41.03

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.21

0.0

1.2

—

37.97

—

Other infections specific to the perinatal period

0.00

0.21

0.0

1.2

—

28.91

—

Psychiatric diseases

327

1585

1.03

0.21

1.3

1.4

28.39

32.61

nmol/l

1.78

284

1477

Slow fetal growth and fetal malnutrition

0.00

0.21

0.0

1.2

—

33.88

—

Nail dystrophy

0.00

0.21

0.0

1.2

—

37.61

—

Superficial injury of wrist and hand

782

0.93

0.21

1.3

33.70

31.27

nmol/l

0.24

709

Acute myeloid leukaemia and myelodysplastic syndromes

0.00

0.21

0.0

1.2

—

30.60

—

Other keratitis

334

1.11

0.21

1.4

41.91

32.27

nmol/l

0.63

297

Reduction defects of lower limb

0.00

0.21

0.0

1.2

—

29.55

—

Other specified/unspecified disorders of ear

0.00

0.21

0.0

1.2

—

35.06

—

Maxillary hypoplasia

0.00

0.21

0.0

1.2

—

31.51

—

Open wound of ankle and foot

241

0.87

0.21

1.5

1.4

32.54

33.04

nmol/l

0.03

215

0.00

0.21

0.0

1.1

—

37.31

—

Other enthesopathy of foot (+metatarsalgia)

220

1.14

0.21

1.2

1.3

15.96

32.51

nmol/l

3.03

200

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.2

—

34.95

—

Reduction defects of lower limb

0.00

0.21

0.0

1.2

—

29.11

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

38.37

—

Osteoporosis with pathological fracture (FG)

0.00

0.21

0.0

1.0

—

25.72

—

Parkinson's disease

0.00

0.21

0.0

1.2

—

22.30

—

Allergic asthma (mode)

128

1192

1.05

0.20

1.4

31.85

32.02

nmol/l

0.02

118

1116

Other congenital musculoskeletal deformities

0.00

0.20

0.0

1.2

—

33.52

—

Parkinson's disease, including avohilmo

0.00

0.20

0.0

1.3

—

25.07

—

Other diseases of the digestive system

282

0.89

0.20

1.3

1.4

22.25

32.10

nmol/l

1.05

250

Nail disorders

155

0.84

0.20

1.6

1.4

24.83

33.14

nmol/l

0.85

132

Syncope and collapse

817

0.94

0.20

1.4

26.36

31.63

nmol/l

1.05

764

Erythema nodosum

1.23

0.20

1.2

31.02

35.24

nmol/l

—

Other and unspecified injuries of shoulder and upper arm

1.23

0.20

1.2

1.4

27.44

34.20

nmol/l

—

Motorcycle rider injured in noncollision transport accidents

1.23

0.20

1.7

1.3

14.28

36.92

nmol/l

—

Allergic asthma (mode), excluding more controls

128

1194

1.05

0.19

1.4

31.85

32.04

nmol/l

0.02

118

1118

Ganglion

655

0.93

0.19

1.3

1.4

29.90

31.76

nmol/l

0.20

596

Infections of genitourinary tract in pregnancy

572

0.93

0.19

1.6

1.4

29.64

34.32

nmol/l

0.45

530

GI-bleeding

281

0.89

0.19

1.3

1.4

21.40

32.26

nmol/l

1.17

251

AV-block

1.17

0.19

1.5

1.1

24.95

32.40

nmol/l

—

Cleft lip, lip and palate or palate

1.16

0.19

1.2

1.3

28.58

35.52

nmol/l

—

Seborrhoeic dermatitis

122

0.82

0.19

1.6

1.3

20.42

31.95

nmol/l

—

102

Asthma mixed form (mode), excluding more controls

118

1.19

0.19

1.7

1.4

25.85

31.18

nmol/l

0.49

103

Hernia of abdominal wall, postoperative

207

0.87

0.19

1.3

1.2

21.75

32.22

nmol/l

0.77

180

Migraine without aura

128

1340

0.95

0.19

1.3

1.4

28.39

32.28

nmol/l

0.90

114

1235

Depression medications

191

998

0.96

0.19

1.4

1.3

30.14

34.44

nmol/l

1.09

165

951

Acne

714

0.94

0.19

1.4

28.71

32.36

nmol/l

0.70

655

HSIL lesion of the cervix uteri

136

1421

0.96

0.18

1.4

31.43

31.56

nmol/l

0.02

128

1308

Paroxysmal tachycardia

452

0.93

0.18

1.3

1.4

26.09

31.61

nmol/l

0.80

401

Abnormal findings on diagnostic imaging of lung

204

1.13

0.18

1.5

1.3

23.13

28.54

nmol/l

0.33

170

Convergent concomitant strabismus

194

1.14

0.18

1.5

1.3

40.09

32.32

nmol/l

0.49

168

COPD, hospital admissions

108

1.17

0.18

1.1

1.3

28.66

29.14

nmol/l

—

Other enthesopathies

518

0.93

0.18

1.1

1.3

16.69

31.55

nmol/l

4.93

466

Open wound of hip and thigh

1.19

0.18

2.1

1.4

27.51

36.84

nmol/l

—

Viral infections characterized by skin and mucous membrane lesions

1020

0.95

0.18

1.4

29.15

31.26

nmol/l

0.38

929

Other protozoal intestinal diseases

1.17

0.18

1.1

1.3

12.94

31.23

nmol/l

—

Codes for special purposes

187

1801

1.04

0.17

1.3

1.4

26.33

32.16

nmol/l

2.44

167

1670

Provisional assignment of new diseases of uncertain etiology

187

1801

1.04

0.17

1.3

1.4

26.33

32.16

nmol/l

2.44

167

1670

Asthma mixed form (mode)

119

1.18

0.17

1.7

1.4

25.85

30.88

nmol/l

0.45

104

COPD, early/later onset

108

1.17

0.17

1.1

1.3

28.66

29.14

nmol/l

—

Struck by thrown, projected or falling objec

1.21

0.17

1.5

1.4

18.76

34.46

nmol/l

1.54

Persons encountering health services for examination and investigation

221

1146

0.97

0.17

1.4

30.58

32.99

nmol/l

0.60

196

1071

Eating disorder

833

1.06

0.17

1.4

32.14

32.45

nmol/l

0.03

765

Other diseases of lip and oral mucosa

786

1.06

0.17

1.3

1.4

28.31

31.11

nmol/l

0.44

711

Mouth breathing

474

1.07

0.17

1.2

1.4

31.01

29.67

nmol/l

0.11

418

Other predominantly sexually transmitted diseases, not elsewhere classified

133

1386

0.96

0.17

1.3

1.4

33.38

31.95

nmol/l

0.24

121

1289

Pedal cyclist injured in transport accident

609

0.94

0.17

1.2

1.4

37.83

31.13

nmol/l

0.76

547

Systemic connective tissue disorders

650

0.94

0.17

1.3

1.4

31.86

31.23

nmol/l

0.05

583

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Progesterone [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS